Mobivity (MFON) 10-K 30 Mar 21 2020 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2020	Mar. 23, 2021	Jun. 30, 2020
Cover [Abstract]
Document Type	10-K
Document Period End Date	Dec. 31, 2020
Entity File Number	000-53851
Entity Registrant Name	Mobivity Holdings Corp.
Entity Incorporation, State Country Code	NV
Tax Identification Number (TIN)	26-3439095
Entity Address, Address Line One	3133 West Frye Road
Entity Address, Address Line Two	# 215
Entity Address, City or Town	Chandler
Entity Address, State or Province	AZ
Entity Address, Postal Zip Code	85226
City Area Code	877
Local Phone Number	282-7660
Trading Symbol	mfon
Title of 12(g) Security	Common Stock, $.001 par value
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	false
Entity Shell Company	false
Entity Public Float			$ 26,270,789
Entity Common Stock, Shares Outstanding		55,410,695
Entity Central Index Key	0001447380
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2020

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Current assets
Cash	$ 3,282,820	$ 273,599
Accounts receivable, net of allowance for doubtful accounts of $33,848 and $88,071, respectively	305,693	614,726
Contracts receivable, current	943,904	526,948
Right to use lease assets	47,038
Other current assets	272,736	601,749
Total current assets	4,852,191	2,017,022
Goodwill	496,352	496,352
Right to use lease assets	10,444	260,645
Intangible assets, net	1,368,329	1,762,211
Contracts receivable, long term	1,415,856	1,260,371
Other assets	25,230	67,787
TOTAL ASSETS	8,168,402	5,864,388
Current liabilities
Accounts payable	1,935,411	3,256,888
Accrued interest	47,316	35,292
Accrued and deferred personnel compensation	224,881	244,953
Deferred revenue and customer deposits	606,597	440,309
Related party notes payable, net - current maturities	80,000	140,700
Notes payable, net - current maturities	561,676	540,576
Operating lease liability	58,173	258,343
Other current liabilities	566,303	308,465
Total current liabilities	4,080,357	5,225,526
Non-current liabilities
Related party notes payable, net - long term		1,000,000
Notes payable, net - long term	1,499,001	567,529
Operating lease liability	13,296	45,460
Other long term liabilities	831,535	740,218
Total non-current liabilities	2,343,832	2,353,207
Total liabilities	6,424,189	7,578,733
Commitments and Contingencies (See Note 13)
Stockholders' equity
Common stock, $0.001 par value; 100,000,000 shares authorized; 55,410,695 and 51,380,969, shares issued and outstanding	55,411	51,381
Equity payable	100,862	100,862
Additional paid-in capital	101,186,889	94,781,738
Accumulated other comprehensive income (loss)	(23,446)	8,780
Accumulated deficit	(99,575,503)	(96,657,106)
Total stockholders' equity	1,744,213	(1,714,345)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 8,168,402	$ 5,864,388

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Consolidated Balance Sheets [Abstract]
Accounts receivable, allowance for doubtful accounts	$ 33,848	$ 88,071
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	55,410,695	51,380,969
Common stock, shares outstanding	55,410,695	51,380,969

Consolidated Statements of Oper

Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Revenues
Revenues	$ 13,255,887	$ 10,056,922
Cost of revenues	4,748,444	5,938,298
Gross profit	8,507,443	4,118,624
Operating expenses
General and administrative	3,917,935	5,588,329
Sales and marketing	2,325,709	2,707,356
Engineering, research, and development	3,535,742	3,609,968
Intangible asset impairment	8,886
Depreciation and amortization	674,942	600,066
Total operating expenses	10,463,214	12,505,719
Loss from operations	(1,955,771)	(8,387,095)
Other income/(expense)
Interest income	1,221	28,160
Interest expense	(286,896)	(236,706)
Loss on disposal of fixed assets	(8,808)
Loss on settlement of debt	(668,260)	(232,462)
Foreign currency gain (loss)	117	6,129
Total other expense	(962,626)	(434,879)
Loss before income taxes	(2,918,397)	(8,821,974)
Income tax expense
Net Loss	(2,918,397)	(8,821,974)
Other comprehensive income (loss), net of income tax
Foreign currency translation adjustments	(32,226)	4,021
Comprehensive loss	$ (2,950,623)	$ (8,817,953)
Net income (loss) per share:
Basic and Diluted	$ (0.06)	$ (0.18)
Weighted average number of shares:
Basic and Diluted	51,575,454	47,720,507

Consolidated Statement of Stock

Consolidated Statement of Stockholders' Equity (Deficit) - USD ($)	Common Stock [Member]	Equity Payable [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive Loss [Member]	Accumulated Deficit [Member]	Total
Beginning balance, value at Dec. 31, 2018	$ 45,998	$ 100,862	$ 88,008,473	$ 4,759	$ (87,835,132)	$ 324,960
Beginning balance, shares at Dec. 31, 2018	45,998,053
Issuance of common stock for cash	$ 2,800		2,797,200			2,800,000
Issuance of common stock for cash, Shares	2,800,000
Issuance of common stock for debt settlement	$ 2,583		2,812,795			2,815,378
Issuance of common stock for debt settlement, Shares	2,582,916
Stock based compensation			1,163,270			1,163,270
Foreign currency translation adjustment				4,021		4,021
Net loss					(8,821,974)	(8,821,974)
Ending balance, value at Dec. 31, 2019	$ 51,381	100,862	94,781,738	8,780	(96,657,106)	$ (1,714,345)
Ending balance, shares at Dec. 31, 2019	51,380,969
Issuance of common stock for cash, Shares						1,113,767
Issuance of common stock for options exercised	$ 1,556		1,932,411			$ 1,933,967
Issuance of common stock for options exercised, Shares	1,556,459
Issuance of common stock for warrants exercised	$ 1,360		1,639,448			1,640,808
Issuance of common stock for warrants exercised, Shares	1,359,500
Issuance of common stock for debt settlement	$ 1,114		2,059,354			2,060,468
Issuance of common stock for debt settlement, Shares	1,113,767
Stock based compensation			773,938			773,938
Foreign currency translation adjustment				(32,226)		(32,226)
Net loss					(2,918,397)	(2,918,397)
Ending balance, value at Dec. 31, 2020	$ 55,411	$ 100,862	$ 101,186,889	$ (23,446)	$ (99,575,503)	$ 1,744,213
Ending balance, shares at Dec. 31, 2020	55,410,695

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
OPERATING ACTIVITIES
Net loss	$ (2,918,397)	$ (8,821,974)
Adjustments to reconcile net loss to net cash used in operating activities:
Bad debt expense	25,583	103,284
Loss on conversion of debt	668,260	232,462
Stock-based compensation	773,938	1,163,270
Loss on disposal of fixed assets	8,808
Intangible Asset Impairment	8,886
Depreciation and amortization expense	696,574	600,066
Increase (decrease) in cash resulting from changes in:
Accounts receivable	282,734	(115,288)
Contracts receivable, current	(416,956)	(51,921)
Other current assets	338,233	569,430
Operating lease assets/liabilities	(33,590)	14,887
Contracts receivable, long-term	(155,485)	516,431
Other assets	14,040	8,615
Accounts payable	(1,321,012)	1,581,238
Accrued interest	204,232	109,041
Accrued and deferred personnel compensation	(20,402)	(106,098)
Other liabilities - non-current	91,317	(31,028)
Other liabilities - current	257,838	(5,178)
Deferred revenue and customer deposits	166,288	(1,516,832)
Net cash used in operating activities	(1,329,111)	(5,749,595)
INVESTING ACTIVITIES
Purchases of equipment	(13,325)	(12,277)
Cash paid for patent	(17,505)	(5,025)
Capitalized software development costs	(266,365)	(539,931)
Net cash used in investing activities	(297,195)	(557,233)
FINANCING ACTIVITIES
Payments on notes payable	(473,586)	(305,345)
Payments on related party notes payable	(60,700)	9,308
Proceeds from notes payable	920,990
Proceeds from related party notes payable	700,000	3,500,000
Proceeds from issuance of common stock, net of issuance costs	3,574,775	2,800,000
Net cash provided by financing activities	4,661,479	6,003,963
Effect of foreign currency translation on cash flow	(25,952)	22,209
Net change in cash	3,009,221	(280,656)
Cash at beginning of period	273,599	554,255
Cash at end of period	3,282,820	273,599
Cash paid during period for:
Interest	75,464	210,581
Taxes	851
Non cash investing and financing activities:
Issuance of common stock for cashless exercise
Issuance of common stock for debt settlement	$ 1,392,208	2,582,916
Lease adoption		$ 538,740

The Company and Summary of Sign

The Company and Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2020
The Company and Summary of Significant Accounting Policies [Abstract]
The Company and Summary of Significant Accounting Policies	1. The Company and Summary of Significant Accounting Policies  The Company  Mobivity Holdings Corp. (the “Company” or “we”) is in the business of developing and operating proprietary platforms over which brands and enterprises can conduct national and localized, data-driven marketing campaigns.  Mobivity’s Recurrency platform enables multi-unit retailers to leverage the power of their own data to yield maximum customer spend, frequency and loyalty while achieving the highest Return on Marketing Spend (ROMS) possible. Mobivity’s customers use Recurrency to: · Transform messy point-of-sale (POS) data collected from thousands of points of sale into usable intelligence. · Measure, predict, and boost guest frequency and spend by channel. · Deploy and manage one-time use offer codes and attribute sales accurately across every channel, promotion and media program. · Deliver 1:1 promotions and offers with customized Mobile Messaging, Personalized Receipt Promotions and Integrated Loyalty programs. Mobivity’s Recurrency, delivered as a SaaS platform, is used by leading brands including Subway, Sonic Drive-In, Chick-fil-A , Checkers/Rally’s and Circle K’s across more than 40,000 retail locations globally. We’re living in a data-driven economy. In fact, by 2003 — when the concept of “big data” became common vernacular in marketing - as much data was being created every two day as had been created in all of time prior to 2003. Today, Big Data has grown at such a rate that 90% of the world’s data has been created in the past two years. Unfortunately, despite there being so much data accumulated, only one percent of data is being utilized today by most businesses.  The challenge for multi-unit retailers isn’t that they don’t have enough data; in fact, national retailers are collecting millions of detailed transactions daily from thousands of points of sale around the world. The challenge is being able to make sense of this transaction data, which is riddled with data entry errors, collected by multiple POS systems and complicated by a taxonomy compiled by thousands of different franchisee owners. To normalize such an overwhelming amount of data into usable intelligence and then leverage it to optimize media investment and promotion strategy requires numerous teams of data analysts and data scientists that many retailers and restaurant operators simply don’t have. Which is why so many technology and data companies, that can help solve these challenges, have been invested in and acquired by brands including, McDonald’s, Starbucks and Yum Brands.  Mobivity’s Recurrency platform fills this need with a self-service SaaS offering, enabling operators to intelligently optimize their promotions, media and marketing spend. Recurrency drives system-wide sales producing on average a 13% increase in guest spend and a 26% improvement in frequency, ultimately delivering an average Return on Marketing Spend of 10X. In other words, for every dollar invested in marketing, retailers using Recurrency to manage, optimize and deliver multi-channel consumer promotions generate an average of ten dollars in incremental revenue from their customers.  We generate revenue by charging the resellers, brands and enterprises a per-message transactional fee, or through fixed or variable software licensing fees.  Liquidity  We have $3,282,820 of cash as of December 31, 20 20 . We had a net loss of $ 2.9 million for the year then ended, and we used $ 1.3 million of cash in our operating activities during 20 20 . In 2019, we had a net loss of $8.8 million and used $5.7 million of cash in our operating expenses. Based on our projected results for the 12 month period from the date of this report and, if necessary, our ability to reduce certain variable operating expenses, we believe that our existing capital, and operations, will be sufficient to finance our operations through 20 21 .  Principles of Consolidation and Basis of Presentation  The accompanying financial statements are consolidated and include the financial statements of Mobivity Holdings Corp. , and our wholly-owned subsidiary. Intercompany transactions are eliminated.  Use of Estimates  Preparation of our consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP) requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying disclosures. These estimates are based on management's best knowledge of current events and actions we may undertake in the future. Significant estimates used are those related to: stock-based compensation; valuation of acquired assets, intangible assets and liabilities; useful lives for depreciation and amortization of long-lived assets; future cash flows associated with impairment testing for goodwill, indefinite-lived intangible assets and other long-lived assets; valuation of derivative liabilities; valuation allowance for deferred tax assets; and contingencies.  Actual results may ultimately differ from estimates, although management does not generally believe such differences would materially affect the consolidated financial statements in any individual year. However, in regard to ongoing impairment testing of goodwill and indefinite-lived intangible assets, significant deterioration in future cash flow projections or other assumptions used in estimating fair values versus those anticipated at the time of the initial valuations, could result in impairment charges that materially affect the consolidated financial statements in a given year.  Reclassifications  Certain prior year amounts have been reclassified to conform to the current year’s presentation. The reclassifications had no effect on previously reported net loss.  Acquisitions  We account for acquired businesses using the purchase method of accounting. Under the purchase method, our consolidated financial statements reflect the operations of an acquired business starting from the completion of the acquisition. In addition, the assets acquired and liabilities assumed are recorded at the date of acquisition at their respective estimated fair values, with any excess of the purchase price over the estimated fair values of the net assets acquired recorded as goodwill.  Cash and Cash Equivalents  We minimize our credit risk associated with cash by periodically evaluating the credit quality of our primary financial institution. Our balances at times may exceed federally insured limits. We have not experienced any losses on our cash accounts.  Accounts Receivable, Allowance for Doubtful Accounts and Concentrations  Accounts receivable are carried at their estimated collectible amounts. We grant unsecured credit to substantially all of our customers. Ongoing credit evaluations are performed, and potential credit losses are charged to operations at the time the account receivable is estimated to be uncollectible. Since we cannot necessarily predict future changes in the financial stability of our customers, we cannot guarantee that our reserves will continue to be adequate.  As of December 31, 20 20 and 201 9 , we recorded an allowance for doubtful accounts of $33,848 and $88,071 , respectively.  From time to time, we may have a limited number of customers with individually large amounts due. Any unanticipated change in one of the customer’s credit worthiness could have a material effect on the results of operations in the period in which such changes or events occurred.  As of December 31, 20 20 , we had two customer whose balance represented 75% of total accounts receivable. As of December 31, 201 9 , we had two customer s whose balance represented 53% of total accounts receivable.  Goodwill and Intangible Assets  Goodwill is tested for impairment at a minimum on an annual basis. Goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. If the reporting unit does not pass the qualitative assessment, then the reporting unit's carrying value is compared to its fair value. The fair values of the reporting units are estimated using market and discounted cash flow approaches. Goodwill is considered impaired if the carrying value of the reporting unit exceeds its fair value. The discounted cash flow approach uses expected future operating results. Failure to achieve these expected results may cause a future impairment of goodwill at the reporting unit.  We conducted our annual impairment tests of goodwill as of December 31, 20 20 and 201 9 . As a result of these tests, we did no t record impairment charges .  Intangible assets consist of patents and trademarks, purchased customer contracts, purchased customer and merchant relationships, purchased trade names, purchased technology, and non-compete agreements. Intangible assets are amortized over the period of estimated benefit using the straight-line method and estimated useful lives ranging from one to twenty years. No significant residual value is estimated for intangible assets. We evaluate long-lived assets (including intangible assets) for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. An asset is considered impaired if its carrying amount exceeds the undiscounted future net cash flow the asset is expected to generate.  The Company’s evaluation of its long-lived assets completed res ulted in no impairment charges during the years ended December 31, 2020 and December 31, 2019.  Software Development Costs Software development costs include direct costs incurred for internally developed products and payments made to independent software developers and/or contract engineers. The Company accounts for software development costs in accordance with the FASB guidance for the costs of computer software to be sold, leased, or otherwise marketed (“ASC Subtopic 985-20”). Software development costs are capitalized once the technological feasibility of a product is established and such costs are determined to be recoverable. Technological feasibility of a product encompasses technical design documentation and integration documentation, or the completed and tested product design and working model. Technological feasibility is evaluated on a project-by-project basis. Amounts related to software development that are not capitalized are charged immediately to the appropriate expense account. Amounts that are considered ‘research and development’ that are not capitalized are immediately charged to engineering, research, and development expense. Capitalized costs for those products that are cancelled or abandoned are charged to impairment expense in the period of cancellation. Commencing upon product release, capitalized software development costs are amortized to “Amortization Expense - Development” based on the straight-line method over a twenty-four month period. The Company evaluates the future recoverability of capitalized software development costs on an annual basis. For products that have been released in prior years, the primary evaluation criterion is ongoing relations with the customer. The Company’s evaluation of its capitalized software development asset resulted in impairment charges of $8,886 for the year ended December 30, 2020 and $0 for the year ended December 31, 2019 .  Derivative Financial Instruments  We do not use derivative instruments to hedge exposures to cash flow, market or foreign currency risks.  We review the terms of the common stock, warrants and convertible debt we issue to determine whether there are embedded derivative instruments, including embedded conversion options, which are required to be bifurcated and accounted for separately as derivative financial instruments. In circumstances where the host instrument contains more than one embedded derivative instrument, including the conversion option, that is required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.  Revenue Recognition and Concentrations  Our Recurrency platform is a hosted solution. We generate revenue from licensing our software to clients in our software as a service model, per-message and per-minute transactional fees, and customized professional services. We recognize license/subscription fees over the period of the contract, service fees as the services are performed, and per-message or per-minute transaction revenue when the transaction takes place. Under Topic 606, revenue is recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. We consider authoritative guidance on multiple deliverables in determining whether each deliverable represents a separate unit of accounting. Some customers are billed on a month to month basis with no contractual term and are collected by credit card. Revenue is recognized at the time that the services are rendered, and the selling price is fixed with a set range of plans. Cash received in advance of the performance of services is recorded as deferred revenue.  During the years ended December 31, 20 20 and 201 9 , two customers accounted for 77% and 70% of our revenues, respectively.  Stock-based Compensation  We primarily issue stock-based awards to employees in the form of stock options. We determine compensation expense associated with stock options based on the estimated grant date fair value method using the Black-Scholes valuation model. We recognize compensation expense using a straight-line amortization method over the respective vesting period.  Research and Development Expenditures  Research and development expenditures are expensed as incurred, and consist primarily of compensation costs, outside services, and expensed materials.  Advertising Expense  Direct advertising costs are expensed as incurred and consist primarily of E-commerce advertisements , sales enablement, content creation, and other direct costs. Advertising expense was $399,266 and $40,993 for years ended December 31, 20 20 and 201 9 , respectively. We also include the cost of attending trade shows under marketing expense. We recorded $81,852 and $139,392 of expense related to those activities for the years ended December 31, 20 20 and 201 9 , respectively.  Income Taxes  We account for income taxes using the assets and liability method, which recognizes deferred tax assets and liabilities determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to affect taxable income. Valuation allowances are established to reduce deferred tax assets when, based on available objective evidence, it is more likely than not that the benefit of such assets will not be realized. We recognize in the consolidated financial statements only those tax positions determined to be more likely than not of being sustained.  Computation of Net Loss per Common Share  Basic net loss per share is based upon the weighted average number of common shares outstanding. Diluted net loss per share is based on the assumption that all potential common stock equivalents (convertible notes payable, stock options, and warrants) are converted or exercised. The calculation of diluted net loss per share excludes potential common stock equivalents if the effect is anti-dilutive. Our weighted average common shares outstanding for basic and diluted are the same because the effect of the potential common stock equivalents is anti-dilutive.  We had the following dilutive common stock equivalents as of December 31, 20 20 and 201 9 which were excluded from the calculation because their effect was anti-dilutive.      December 31,  20 20 201 9  Outstanding employee options 6,007,552 5,781,884  Outstanding restricted stock units 1,436,728 1,152,248  Outstanding warrants 2,691,459 3,358,459  10,135,739 10,292,591  Recent Accounting Pronouncements  Accounting standards promulgated by the FASB are subject to change. Changes in such standards may have an impact on the Company’s future financial statements. The following are a summary of recent accounting developments. In February 201 6, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-02, “Leases (Topic 842)”. Under this guidance, an entity is required to recognize right-of-use assets and lease liabilities on its balance sheet and disclose key information about leasing arrangements. This guidance offers specific accounting guidance for a lessee, a lessor and sale and leaseback transactions. Lessees and lessors are required to disclose qualitative and quantitative information about leasing arrangements to enable a user of the financial statements to assess the amount, timing and uncertainty of cash flows arising from leases. This guidance is effective for annual reporting periods beginning after December 15, 2018, including interim periods within that reporting period, and requires a modified retrospective adoption, with early adoption permitted. The Company adopted this standard as of January 1, 2019.  In November 201 6, the FASB issued ASU No. 2016-18, “Statement of Cash Flows (Topic 230).” ASU No. 2016-18 requires that restricted cash be included with cash and cash equivalents when reconciling the change in cash flow. The Company adopted this standard as of January 1, 2019.

Acquisitions

Acquisitions	12 Months Ended
	Dec. 31, 2020
Acquisitions [Abstract]
Acquisitions	2. Acquisitions  We did no t have any acquisitions in 2020 or 2019.

Goodwill and Intangible Assets

Goodwill and Intangible Assets	12 Months Ended
	Dec. 31, 2020
Goodwill and Intangible Assets [Abstract]
Goodwill and Intangible Assets	3 . Goodwill and Intangible Assets  Goodwill  The following table presents goodwill and impairment for the years ended December 31, 20 20 and 201 9 :      Goodwill  December 31, 2018 $ 537,550  Acquired (41,198)  Impairment —  December 31, 2019 496,352  Acquired —  Impairment —  December 31, 2020 $ 496,352  We conducted our annual impairment test of goodwill as of December 31, 20 20 and 201 9 , which resulted in no impairment charges. During the year ended December 31, 2019, there was an adjustment for $41,198 to correct the goodwill recorded related to the acquisition of Belly.  Intangible assets  The following table presents components of identifiable intangible assets for the years ended December 31, 20 20 and 201 9 :      December 31, 2020 December 31, 2019  Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Average Useful Life (Years) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Average Useful Life (Years)  Patents and trademarks $ 197,528 $ (126,499) $ 71,029 14 $ 183,583 $ (113,730) $ 69,853 14  Customer and merchant relationships 2,321,112 (1,678,727) 642,385 10 2,321,112 (1,581,876) 739,236 10  Trade name 197,950 (156,506) 41,444 10 197,924 (147,192) 50,732 10  Acquired technology 621,030 (492,539) 128,491 10 684,540 (539,748) 144,792 10  Non-compete agreement 79,299 (34,228) 45,071 2 79,299 (18,368) 60,931 2  $ 3,416,919 $ (2,488,499) $ 928,420 $ 3,466,458 $ (2,400,914) $ 1,065,544  During the years ended December 31, 20 20 and 201 9 , we recorded amortization expense related to our intangible assets of $150,701 and $178,653 , respectively, which is included in depreciation and amortization in the consolidated statement of operations.  During the years ended December 31, 20 20 and 201 9 , we recorded no impairment charges related to our intangible assets.  Expected future intangible asset amortization as of December 31, 20 20 is as follows:      Year ending December 31, Amount  2021 $ 147,992  2022 147,868  2023 145,359  2024 108,763  2025 101,015  Thereafter 277,423  Total $ 928,420  

Software Development Costs

Software Development Costs	12 Months Ended
	Dec. 31, 2020
Software Development Costs [Abstract]
Software Development Costs	4 . Software Development Costs  The Company has capitalized certain costs for software developed or obtained for internal use during the application development stage as it relates to specific contracts. The amounts capitalized include external direct costs of services used in developing internal-use software and for payroll and payroll-related costs of employees directly associated with the development activities.  The following table presents details of our software development costs for the years ended December 31, 2020 and 2019:      December 31, 2020 December 31, 2019  Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Average Useful Life (Years) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Average Useful Life (Years)  $ 2,266,272 $ (1,826,364) $ 439,908 2 $ 2,245,811 $ (1,549,144) $ 696,667 2  $ 2,266,272 $ (1,826,364) $ 439,908 $ 2,245,811 $ (1,549,144) $ 696,667  Software development costs are being amortized on a straight-line basis over their estimated useful life of two years.  During the years ended December 31, 20 20 and 2019 , we capitalized $266,365 and 539,932 respectively of software development. W e recorded amortization expense for software development costs of $518,087 and $309,736 , respectively which is included in depreciation and amortization in the consolidated statement of operations.  During the years ended December 31, 20 20 and 201 9 , we recorded impairment charges of $8,886 and $0 , respectively related to our software development costs.  The estimated future amortization expense of software development costs as of December 31, 20 20 is as follows:      Year ending December 31, Amount  2021 345,643  2022 94,265  2023 —  2024 —  2025 —  Thereafter —  Total $ 439,908

Operating Lease Assets

Operating Lease Assets	12 Months Ended
	Dec. 31, 2020
Operating Lease Assets [Abstract]
Operating Lease Assets	5. Operating Lease Assets  Adoption of Accounting Standards Codification (“ASC”) Topic 842, “Leases." The Company adopted Topic 842 on January 1, 2019, using the modified retrospective method and the optional transition method to record the adoption impact through a cumulative adjustment to equity. Results for reporting periods beginning after January 1, 2019, are presented under Topic 842, while prior periods are not adjusted and continue to be reported under the accounting standards in effect for those periods.  The following are additional details related to leases recorded on our b alance s heet as of December 31 , 2020 :     Leases Classification Balance at December 31, 2020  Assets  Current  Operating lease assets Operating lease assets $ 47,038  Noncurrent  Operating lease assets Noncurrent operating lease assets 10,444  Total lease assets $ 57,482   Liabilities  Current  Operating lease liabilities Operating lease liabilities $ 58,173  Noncurrent  Operating lease liabilities Noncurrent operating lease liabilities $ 13,296  Total lease liabilities $ 71,469  During the year ended December 31, 20 20, we recorded a credit to amortization expense of $17,214 and during the year ended December 31, 2019, we recorded expenses of $4,419 related to the accretion of the lease liability , which is included in depreciation and amortization in the consolidated statement of operations.  Rent expense was $317,774 and $320,496 for the years ended December 31, 20 20 and 201 9, respectively .  We have entered into a new lease starting in February of 2021 for 8,898 square feet of office space located at 3133 W. Frye Road, Suite 215, Chandler, Arizona. Monthly rental payments, excluding common area maintenance charges, will be $25,953 to $28,733 . The first twelve months of the lease includes a 50% abatement period. An operating lease asset and liability will be recorded when the lease commences in accordance with ASC 842.  The maturity analysis below summarizes the remaining future undiscounted cash flows for our operating leases, a reconciliation to operating lease liabilities reported on the Condensed Consolidated Balance Sheet, our weighted-average remaining lease term and weighted average discount rate:      Year ending December 31, Amount  2021 $ 60,592  2022 13,484  2023 —  2024 —  2025 —  Thereafter —  Total future lease payments 74,076  Less: imputed interest (2,607)  Total $ 71,469      Weighted Average Remaining Lease Term (years)  Operating leases 0.57   Weighted Average Discount Rate  Operating leases 6.75%

Notes Payable and Interest Expe

Notes Payable and Interest Expense	12 Months Ended
	Dec. 31, 2020
Notes Payable and Interest Expense [Abstract]
Notes Payable and Interest Expense	6 . Notes Payable and Interest Expense  Notes Payable  The following table presents details of our notes payable as of December 31, 20 20 and 201 9 :      Facility Maturity Interest Rate Balance at December 31, 2020 Balance at December 31, 2019  BDC Term Loan October 15, 2021 23.5% $ 160,088 $ 224,307  ACOA Note February 1, 2024 — 111,430 117,131  Wintrust Bank November 1, 2021 Prime + 1.5% 366,667 766,667  TD Bank December 31, 2022 — 31,390 —  Chase Bank April 10, 2022 1% 891,102 —  Related Party Notes various 15% 580,000 1,140,700  Total Debt 2,140,677 2,248,805  Less current portion (641,676) (681,276)  Long-term debt, net of current portion $ 1,499,001 $ 1,567,529  Principal payments on notes payables are due as follows:      Year ending December 31, Amount  2021 $ 641,676  2022 1,462,121  2023 33,410  2024 3,470  2025 —  Thereafter —  Total future debt payments 2,140,677  BDC Term Loan  On January 8, 2016, Livelenz, a wholly-owned subsidiary of the Company (“Livelenz”), entered into an amendment of their original loan agreement dated August 26, 2011 with the Business Development Bank of Canada (“BDC”). Under this agreement the loan would have matured, and the commitments would have terminated on September 15, 2019. On July 26, 2019, Livelenz, entered into an amendment of their original loan agreement dated August 26, 2011 with the Business Development Bank of Canada (“BDC”). Under this agreement the loan will mature, and the commitments will terminate on October 15, 2021 . In accordance with the amendment, the Company will commence monthly payments beginning on August 15, 2019 of principal in the amount of $8,500 CAD in addition to the monthly payment of accrued interest at 23.5% . These payments increase d to $10,000 CAD on November 15, 2019, $12,000 CAD on May 15, 2020, and will increase to $14,000 CAD on March 15, 2021 with the final payments of $16,000 CAD on September 15, 2021 and $80,000 CAD on October 15, 2021 in addition to the monthly interest. During the twelve months ended December 31 , 2020 we repaid $88,000 CAD of principal.  ACOA Note  On November 6 , 2017, Livelenz (a wholly-owned subsidiary of the Company), entered into an amendment of the original agreement dated December 2, 2014 with the Atlantic Canada Opportunities Agency (“ACOA”). Under this agreement the note will mature without interest and repayments began on June 1, 2016 , while the commitments will terminate on February 1, 2024 . T he monthly principal payment amount of $3,000 CAD increased to $3,500 CAD beginning on November 1, 2019, and will increase to $4,000 CAD on August 1, 2021, $4,500 CAD on August 1, 2022 and $2,215 CAD during the remaining term of the agreement. During the twelve months ended December 31, 2020, we repaid $10,485 CAD of principal. Nine months of payments were voluntarily deferred by ACOA due to COVID-19.  Wintrust Loan  On November 14, 2018, we entered into a Loan and Security Agreement with Wintrust Bank. The Loan and Security Agreement provides for a single-term loan to us in the original principal amount of $1,000,000 . Interest accrues on the unpaid principal amount at the rate of prime plus 1.5% . The loan is a three -year loan and was interest-only payable for the first six months of the loan. Commencing on May 1, 2019, we made monthly payments of principal in the amount of $33,333 in addition to the monthly payment of accrued interest. The loan is secured by all of our assets other than our intellectual property. We used the proceeds of the loan to re-finance a loan in the principal amount of $1,000,000 we assumed as part of the acquisition of the Belly assets.  On August 7, 2020, the Company entered into an amendment of their original loan agreement dated November 14, 2018 with Wintrust Bank. Under this agreement, the covenant calculation was amended to calculate covenants under a borrowing base methodology. The Company had defaulted under the March 31, 2020 and June 30, 2020 covenants, which were waived upon execution of the amendment and there were no defaults after the amendment. During the twelve months ended December 31, 2020, we repaid $400,000 of principal.  Chase Loan On April 10, 2020, we entered into a commitment loan with Chase Bank, N.A. under the CARES act and SBA Paycheck Protection Program, in the principal aggregate amount of $891,102 , which is due and payable two years after issuance. This note bears interest on the unpaid balance at the rate of one percent ( 1% ) per annum. The note contains a deferral period of six months, for which no interest or principal payments are due. Forgiveness of the loan may be obtained by meeting certain SBA requirements. TD Bank Loan On April 22, 2020, we entered into a commitment loan with TD Bank under the Canadian Emergency Business Account (“CEBA”), in the principal aggregate amount of $40,000 CAD, which is due and payable on December 31, 2022 . This note bears interest on the unpaid balance at the rate of zero percent ( 0% ) per annum during the initial term. Under this note no interest or principal payments are due until December 31, 2022. Under the conditions of the loan, twenty-five percent ( 25% ) of the loan will be forgiven if seventy-five percent ( 75% ) is repaid prior to the initial term date.  Related Party Notes  During February 201 8, we conducted a private placement of Unsecured Promissory Notes (individually, a “Note” and collectively, the “Notes”) in the aggregate principal amount of $1,080,000 to certain investors, officers and directors of the Company. Each Note bears interest on the unpaid balance at the rate of fifteen percent ( 15% ) per annum and the principal and accrued interest is due and payable no later than December 1, 2018. We may prepay any of the Notes without notice, subject to a two percent ( 2% ) pre-payment penalty. The Note offer was conducted by our management and there were no commissions paid by us in connection with the solicitation. During 2019, we repaid $1,000,000 and ha d $80,000 as a remaining balance of these N otes plus accrued interest .  During the year ended December 31, 2019 we issued unsecured Notes in the principle aggregate amount of $3,500,000 , which become due two years after the date of issuance. These Notes bear interest on the unpaid balance at the rate of fifteen percent ( 15% ) per annum. The Company may prepay any of the Notes without notice, subject to a two p ercent ( 2% ) pre-payment penalty.  On July 2, 2019, $2,500,000 of this Note and the accrued interest of $82,916 was settled into equity and we recorded a loss on conversion of debt of $232,462 for the year ended December 31, 2019. As of December 31, 2019, we had a principal balance of $1,080,000 as a remaining balance of these Notes plus accrued interest.  On February 26, 2020, we issued an unsecured Note in the principle aggregate amount of $200,000 , which becomes due two years after the date of issuance. This Note bears interest on the unpaid balance at the rate of fifteen percent ( 15% ) per annum. The Company may prepay this Note without notice, subject to a two percent ( 2% ) pre-payment penalty.  On November 18, 2020, we issued two additional unsecured Notes in the principle aggregate amount of $500,000 , which becomes due two years after the date of issuance. This Note bears interest on the unpaid balance at the rate of fifteen percent ( 15% ) per annum. The Company may prepay this Note without notice, subject to a two percent ( 2% ) pre-payment penalty.  On December 31, 2020 $1,200,000 of these Notes and the accrued interest of $192,208 was settled into equity and we recorded a loss on settlement of debt of $668,260 for the year ended December 31, 2020. In summary, as of December 31, 2020, we have a principal balance of $580,000 and accrued interest of $42,492 outstanding.  Interest Expense  The following table summarizes interest expense for the years ended December 31, 20 20 and 201 9 :      December 31,  2020 2019  Interest expense $ 286,896 $ 236,706  Total interest expense $ 286,896 $ 236,706

Common Stock and Equity Payable

Common Stock and Equity Payable	12 Months Ended
	Dec. 31, 2020
Common Stock and Equity Payable [Abstract]
Common Stock and Equity Payable	7 . Common Stock and Equity Payable  Common Stock  2019  In July 2019, the Company commenced a private placement of its common stock units , with each unit consisting of one share of our common stock and a warrant to purchase to one-half share of our common stock at an exercise price of $1.25 per share at an offering price of $1.00 per unit . As of December 31, 201 9 , the Company had sold 2,800,000 units of its common stock for gross proceeds of $2,800,000 . In addition , the Company issued 2,582,916 units of its common stock associated with the settlement of $2,500,000 of principal, $82,916 of accrued interest, and a loss on settlement of $232,462 (See Note 6 ).  On December 31, 2019, the Company recorded stock-based compensation expense of $263,378 related to restricted stock units for members of our board of directors.  As of December 31, 2019 we had an equity payable balance of $100,862 .  2020 On March 2, 2020, the Company issued 234,500 shares of common stock in exchange for cash in conjunction with a warrant exercise. The shares were exercised at the strike price of $1.00 per share. On September 17, 2020, the Company issued 15,000 shares of common stock in exchange for cash in conjunction with a stock option exercise. The shares were exercised at the strike price of $0.48 per share.  In December of 2020, the Company commenced a private placement of its common stock with warrant exercises for one unit of our common stock at an exercise price of $1.25 per share to receive a new warrant t o purchase to one share of our common stock at an exercise price of $2.00 per share . As of December 31, 20 20 , the Company had sold 2,666,459 units of its common stock for gross proceeds of $3,333,074 . In addition , the Company issued 1,113,767 units of its common stock associated with the settlement of $1,200,000 of principal, $192,208 of accrued interest, and a loss on settlement of $668,260 (See Note 6 ).  On December 31, 2020, the Company recorded stock-based compensation expense of $260,003 related to restricted stock units for members of our board of directors.  As of December 31, 2020 we had an equity payable balance of $100,862 .

Stock-based Plans and Stock-bas

Stock-based Plans and Stock-based Compensation	12 Months Ended
	Dec. 31, 2020
Stock-based Plans and Stock-based Compensation [Abstract]
Stock-based Plans and Stock-based Compensation	8 . Stock-based Plans and Stock-based Compensation  Stock-based Plans  We have the 2010 Incentive Stock Option Plan and the 2013 Incentive Stock Option Plan under which we have granted stock options to our directors, officers and employees. At December 31, 20 20 , 3,477,356 shares were authorized under the plans and 33,032,730 shares were available for future grant.  We believe that such awards better align the interests of our directors, officers and employees with those of our shareholders. Option awards are generally granted with an exercise price that equals the fair market value of our stock at the date of grant. These option awards generally vest based on four years of continuous service and have 10 -year contractual terms.  The following table summarizes stock option activity under our stock-based plans as of and for the years ended December 31, 20 20 and 201 9 :      Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Years) Aggregate Intrinsic Value  Outstanding at December 31, 2018 4,987,426 $ 1.16 7.12 $ 1,215,067  Granted 2,592,500 $ 1.01 — $ —  Exercised — —  Forfeit/canceled (923,389) $ 1.00 — $ —  Expired (874,653) $ 0.93 — $ —  Outstanding at December 31, 2019 5,781,884 $ 1.15 7.16 $ 527,868  Granted 1,545,000 $ 1.19 — $ —  Exercised (15,000) $ 0.48 — $ —  Forfeit/canceled (814,068) $ 0.94 — $ —  Expired (490,264) $ 1.07 — $ —  Outstanding at December 31, 2020 6,007,552 $ 1.20 6.77 $ 4,056,639   Expected to vest at December 31, 2020 6,007,552 $ 1.24 6.77 $ 4,056,639  Exercisable at December 31, 2020 3,477,356 $ 1.24 5.15 $ 2,252,766  Unrecognized expense at December 31, 2020 $ 1,734,104  The aggregate intrinsic value of options was calculated as the difference between the exercise price of the underlying awards and the quoted price of our common stock. At December 31, 20 20 , options to purchase 5,990,884 shares of common stock were in-the-money.  The weighted average grant-date fair value of options granted during the years 20 20 and 20 19 was $0.79 and $0.71 , respectively.  201 9  On January 7 , 201 9 , the Company granted one employee a total of 1 0,000 options to purchase shares of the Company common stock at the closing price as of January 7 , 201 9 of $1.17 per share. The Option Shares will vest ratably over forty-eight (48) months and are exercisable until January 7 , 202 9 . The total estimated value using the Black-Scholes Model, based on a volatility rate of 90.82% and an option fair value of $.88 was $8,821 .  On January 21, 2019, the Company granted one employee a total of 1 5,000 options to purchase shares of the Company common stock at the closing price as of January 21, 2019 of $1.17 per share. The o ption s hares will vest ratably over forty-eight (48) months and are exercisable until January 21 , 202 9 . The total estimated value using the Black-Scholes Model, based on a volatility rate of 90.75% and an option fair value of $0.88 was $ 13,239 .  On February 12 , 201 9 , the Company granted one employee a total of 1 50,000 options to purchase shares of the Company common stock at the closing price as of February 12 , 201 9 of $1.00 per share. The option shares will vest ratably over forty-eight (48) months and are exercisable until February 12 , 202 9 . The total estimated value using the Black-Scholes Model, based on a volatility rate of 90.79% and an option fair value of $0.75 was $113,046 .  On February 18 , 201 9 , the Company granted one employee a total of 1 5,000 options to purchase shares of the Company common stock at the closing price as of February 18 , 201 9 of $1.05 per share. The option shares will vest ratably over forty-eight (48) months and are exercisable until February 18 , 202 9 . The total estimated value using the Black-Scholes Model, based on a volatility rate of 90.88% and an option fair value of $0.84 was $12,537 .  On February 25 , 201 9 , the Company granted one employee a total of 50 ,000 options to purchase shares of the Company common stock at the closing price as of February 25 , 201 9 of $1.00 per share. The option shares will vest ratably over forty-eight (48) months and are exercisable until February 25 , 202 9 . The total estimated value using the Black-Scholes Model, based on a volatility rate of 90.88% and an option fair value of $0.75 was $37,697 .  On March 11 , 201 9 , the Company granted one employee a total of 50 ,000 options to purchase shares of the Company common stock at the closing price as of March 11 , 201 9 of $1.00 per share. 775,000 option shares will vest ratably over forty-eight (48) months and are exercisable until March 11 , 202 9 . 500,000 option shares will vest immediately, and 500,000 option shares will vest on May 17, 2023. The total estimated value using the Black-Scholes Model, based on a volatility rate of 90.90% and an option fair value of $0.75 was $37,688 .  On May 17 , 201 9 , the Company granted three employee s a total of 1,775 ,000 options to purchase shares of the Company common stock at the closing price as of May 17 , 201 9 of $1.04 per share. The option shares will vest ratably over forty-eight (48) months and are exercisable until May 17 , 202 9 . The total estimated value using the Black-Scholes Model, based on a volatility rate of 80.17% and an option fair value of $0.72 was $1,283,178 .  On August 21, 2019, the Company granted four employee s a total of 140,000 options to purchase shares of the Company common stock at the closing price as of August 21 , 201 9 of $0.95 per share. The option shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter and are exercisable until August 21, 2029. The total estimated value using the Black-Scholes Model, based on a volatility rate of 80.17% and an option fair value of $0.65 was $91,537 .  On October 21, 2019, the Company granted one employee 150 ,000 options to purchase shares of the Company common stock at the closing price as of October 21 , 201 9 of $0.98 per share. The option shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter and are exercisable until October 21, 2029. The total estimated value using the Black-Scholes Model, based on a volatility rate of 74.18% and an option fair value of $0.64 was $96,165 .  On November 19, 2019, the Company granted twelve employee s a total of 237,500 options to purchase shares of the Company common stock at the closing price as of November 19 , 201 9 of $0.88 per share. The option shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter and are exercisable until November 19, 2029. The total estimated value using the Black-Scholes Model, based on a volatility rate of 78.70% and an option fair value of $0.60 was $142,409 .  2020  On March 24, 2020, the Company granted one employee a total of 15 ,000 options to purchase shares of the Company common stock at the closing price as of March 24, 2020 of $0.65 per share. The option shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter and are exercisable until March 24, 2030. The total estimated value using the Black-Scholes Model, based on a volatility rate of 77.56% and an option fair value of $0.43 was $6,472 .  On April 6, 2020, the Company granted four employees a total of 700 ,000 options to purchase shares of the Company common stock at the closing price as of April 6, 2020 of $0.70 per share. 500,000 option shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter and are exercisable until April 6, 2030. 200,000 option shares will vest ratably over forty-eight (48) months and are exercisable until April 6, 2030. The total estimated value using the Black-Scholes Model, based on a volatility rate of 78.21% and an option fair value of $0.47 was $326,752 .  On November 5, 2020, the Company granted one employee a total of 20 ,000 options to purchase shares of the Company common stock at the closing price as of November 5, 2020 of $0.96 per share. The option shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter and are exercisable until November 5, 2030. The total estimated value using the Black-Scholes Model, based on a volatility rate of 77.36% and an option fair value of $0.63 was $12,689 .  On December 7, 2020, the Company granted one employee a total of 600 ,000 options to purchase shares of the Company common stock at the closing price as of December 7, 2020 of $1.55 per share. The option shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter and are exercisable until December 7, 2030. The total estimated value using the Black-Scholes Model, based on a volatility rate of 77.35% and an option fair value of $1.03 was $615,495 .  On December 17, 2020, the Company granted six employees a total of 210 ,000 options to purchase shares of the Company common stock at the closing price as of December 17, 2020 of $1.83 per share. The option shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter and are exercisable until December 17, 2030. The total estimated value using the Black-Scholes Model, based on a volatility rate of 77.41% and an option fair value of $1.21 was $254,373 .  Stock-based Compensation Expense  The impact on our results of operations of recording stock-based compensation expense for the years ended December 31, 20 20 and 201 9 was as follows:      Years Ended  December 31,  2020 2019  General and administrative $ 267,306 $ 670,188  Sales and marketing 75,235 74,229  Engineering, research, and development 171,394 155,475  $ 513,935 $ 899,892  As of December 31, 20 20 , there was approximately $1,734,104 of unearned stock-based compensation that will be expensed from 20 21 through 202 5 . If there are any modifications or cancellations of the underlying unvested awards, we may be required to accelerate, increase or cancel all or a portion of the remaining unearned stock-based compensation expense. Future unearned stock-based compensation will increase to the extent we grant additional equity awards.  Stock Option Valuation Assumptions  We calculated the fair value of each stock option award on the date of grant using the Black-Scholes option pricing model. The ranges of assumptions were used for the years ended December 31, 20 20 and 201 9 :      Years Ended  December 31,  2020 2019  Risk-free interest rate 0.42% to 0.58% 1.49% to 2.65%  Expected life (years) 6.00 6.06  Expected dividend yield — —  Expected volatility 77.36% to 78.21% 74.18% to 90.90%   The risk-free interest rate assumption is based upon published interest rates appropriate for the expected life of our employee stock options.  The expected life of the stock options represents the weighted-average period that the stock options are expected to remain outstanding and was determined based on historical experience of similar awards, giving consideration to the contractual terms of the stock-based awards, vesting schedules and expectations of future employee behavior as influenced by changes to the terms of its stock-based awards.  The dividend yield assumption is based on our history of not paying dividends and no future expectations of dividend payouts.  The expected volatility in 20 20 and 201 9 is based on the historical publicly traded price of our common stock.  Restricted stock units  The following table summarizes restricted stock unit activity under our stock-based plans as of and for the years ended December 31, 20 20 and 201 9 :      Shares Weighted Average Grant Date Fair Value Weighted Average Remaining Contractual Term (Years) Aggregate Intrinsic Value  Outstanding at December 31, 2018 662,800 $ 0.72 0.70 $ 795,360  Awarded 489,448 $ 1.04 — $ 325,044  Released — $ — — $ —  Canceled/forfeited/expired — $ — — $ —  Outstanding at December 31, 2019 1,152,248 $ 0.86 — $ 1,120,404  Awarded 284,480 $ 0.91 — $ 60,003  Released — $ — — $ —  Canceled/forfeited/expired — $ — — $ —  Outstanding at December 31, 2020 1,436,728 $ 0.86 — $ 1,180,407   Vested at December 31, 2020 1,436,728 $ — — $ 2,428,070  Unvested at December 31, 2020 — $ — — $ —  Unrecognized expense at December 31, 2020 $ —  201 9  On January 1 , 201 9, the Company issued to four independent directors a total of 222,224 restricted stock units. These restricted stock units were issued for the $260,000 of board compensation earned in 2018. The units were valued at $260,000 or $1.17 per share, based on the closing stock price on the date of grant. All units vest ed immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) January 1 , 202 2 , (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.  On March 31 , 201 9, the Company granted four independent directors a total of 72,224 restricted stock units. The units were valued at $65,001 or $0.90 per share, based on the closing stock price on the date of grant. All units vest ed immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) March 31 , 202 2 , (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.  On December 31 , 201 9, the Company granted four independent directors a total of 195,000 restricted stock units. The units were valued at $195,000 or $1.00 per share, based on the closing stock price on the date of grant. All units vest ed immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) December 31 , 202 2 , (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.  2020  On March 24, 2020, the Company issued to four independent directors a total of 100,000 restricted stock units. These restricted stock units were issued for the $65,000 of board compensation earned for the first quarter of 2020. The units were valued at $ 65,000 or $0.65 per share, based on the closing stock price on the date of grant. All units vest ed immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) March 24 , 202 3 , (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.  On August 7, 2020, the Company granted four independent directors a total of 81,252 restricted stock units. The units were valued at $65,000 or $0.80 per share, based on the closing stock price on the date of grant. All units vest ed immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) August 7 , 202 3 , (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.  On November 5, 2020, the Company granted four independent directors a total of 67,708 restricted stock units. The units were valued at $65,000 or $0.96 per share, based on the closing stock price on the date of grant. All units vest ed immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) November 5 , 202 3 , (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.  On December 17, 2020, the Company granted four independent directors a total of 35,520 restricted stock units. The units were valued at $65,000 or $1.83 per share, based on the closing stock price on the date of grant. All units vest ed immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) December 17 , 202 3 , (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.  In the twelve months ended December 31, 2020 and 2019, the company recorded $260,003 and $263,378 , respectively, in restricted stock units as board compensation.  Restricted Stock Unit Compensation Expense  The impact on our results of operations of recording stock-based compensation expense for years ended December 31, 20 20 and 201 9 was as follows:      Years Ended  December 31,  2020 2019  General and administrative $ 260,003 $ 263,378  $ 260,003 $ 263,378

Warrants to Purchase Common Sto

Warrants to Purchase Common Stock	12 Months Ended
	Dec. 31, 2020
Warrants to Purchase Common Stock [Abstract]
Warrants to Purchase Common Stock	9 . Warrants to Purchase Common Stock  The following table summarizes investor warrant activity as of and for the years ended December 31, 20 20 and 201 9 :      Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Years)  Outstanding at December 31, 2018 2,112,060 $ 1.19 1.17  Granted 2,691,459 $ — —  Exercised — $ — —  Canceled/forfeited/expired (1,445,060) $ — —  Outstanding at December 31, 2019 3,358,459 $ 1.23 1.27  Granted 2,666,459 $ — —  Exercised (2,900,959) $ — —  Canceled/forfeited/expired (432,500) $ — —  Outstanding at December 31, 2020 2,691,459 $ 1.99 2.94 We did no t record any stock-based compensation expense for the year s ended December 31, 20 20 and 201 9 , respectively in connection with the exercise of investor-based warrants.  Warrants Exercised in 2020  On March 2, 2020 one warrant holder exercised their common stock purchase warrant for 234,500 shares at the exercise price of $1.00 per share, resulting in additional capital of $234,500 . In December 2020, w arrant holders exercised warrants to purchase common stock at $1.25 per share. At the commencement of the December warrant exercise , there were warrants outstanding that entitled their holders to purchase 2,691,459 shares of our common stock at exercise prices of $1.25 per share. Pursuant to the offer, warrant holders exercised warrants to purchase 2,666,459 shares of our common stock, resulting in additional capital of $3,333,074 . As part of the exercise, 2,666,459 new warrants were issued to purchase common stock at $2.00 per share within three years .

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2020
Income Taxes [Abstract]
Income Taxes	10 . Income Taxes  On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (the CARES Act) was enacted and signed into law in response to the market volatility and instability resulting from the COVID-19 pandemic. It includes a significant number of tax provisions and lifts certain deduction limitations originally imposed by the Tax Cuts and Jobs Act of 2017 (the 2017 Act). The changes are mainly related to: (1) the business interest expense disallowance rules for 2019 and 2020; (2) net operating loss rules; (3) charitable contribution limitations; (4) employee retention credit; and (5) the realization of corporate alternative minimum tax credits. The Company does not anticipate the application of the CARES Act provisions to materially impact the overall Consolidated Financial Statements.  For the years ended December 31, 20 20 and 201 9 the provisions for income taxes were as follows:     2020 2019  Federal – current $ — $ —  State – current — —  Foreign – current — —  Total $ — $ —  Under ASC 740, deferred income tax assets and liabilities reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.  Significant components of our net deferred tax assets and liabilities as of December 31, 20 20 and 201 9 are as follows:     2020 2019  Deferred tax assets (liabilities):  Net operating loss carryforwards $ 14,881,000 $ 14,136,000  Stock based compensation 4,094,000 3,877,000  Accrued compensation 19,000 34,000  Depreciation and amortization 3,867,000 4,241,000  Other — 5,000  Total deferred tax assets 22,861,000 22,293,000  Valuation allowance for net deferred tax assets (22,861,000) (22,293,000)  Total $ — $ —  The Company has provided a valuation allowance against deferred tax assets recorded as of December 31, 20 20 and 201 9 due to uncertainties regarding the realization of such assets.  The net change in the total valuation allowance for the year ended December 31, 2020 was an increase of approximately $568,000 . The net change in the total valuation allowance for the year ended December 31, 2019 was an increase of approximately $2,326,000 . In assessing the valuation of deferred tax assets, the Company considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during periods in which those temporary differences become deductible. The Company considers projected future taxable income and planning strategies in making this assessment. Based on the level of historical operating results and projections for the taxable income for the future, the Company has determined that it is more likely than not that the deferred tax assets will not be realized. Accordingly, the Company has recorded a valuation allowance to reduce deferred tax assets to zero. There can be no assurance that the Company will ever be able to realize the benefit of some or all of the federal and state loss carryforwards, either due to ongoing operating losses or due to ownership changes, which limit the usefulness of the loss carryforwards.  As of December 31, 2020, the Company has available net operating loss carryforwards of approximately $53,000,000 for federal income tax purposes, which will start to expire in 2026. The net operating loss carryforwards for state purposes are approximately $53,000,000 and will start to expire in 2028.  The difference between the provision for income taxes and income taxes computed using the U.S. federal income tax rate for the years ended December 31, 20 20 and 201 9 was as follows:     2020 2019  Computed expected tax expense $ (613,000) $ (1,853,000)  State taxes, net of federal benefit (141,000) (581,000)  Expiration of NOL carryforwards 44,000 44,000  Other 142,000 64,000  Change in valuation allowance 568,000 2,326,000  Total $ — $ —  The Company has determined that during 2010 it experienced a “change of ownership” as defined by Section 382 of the Internal Revenue Code. As such, utilization of net operating loss carryforwards and credits generated before the 2010 change in ownership will be limited to approximately $207,000 per year until such carryforwards are fully utilized. The pre change net operating loss carryforward was approximately $6,000,000 . Since 2010 the Company has not conducted a study to assess whether a change of control has occurred or whether there have been multiple changes of control since inception due to the significant complexity and cost associated with such a study. If the Company has experienced a change of control, as defined by Section 382, at any time since 2010, utilization of the net operating loss carryforwards tax credit carryforwards would be subject to further annual limitation under Section 382. Any limitation may result in expiration of a portion of the net operating loss carryforwards before utilization.  The Company files income tax returns in the U.S. federal jurisdiction, Arizona, and California. Because the Company is carrying forward federal and state net operating losses from 2006 , the Company is subject to U.S. federal and state income tax examinations by tax authorities for all years since 2006 . The Company does no t have a liability for any uncertain tax positions. As of December 31, 20 20 , no accrued interest or penalties are recorded in the financial statements.

Fair Value Measurements of Fina

Fair Value Measurements of Financial Instruments	12 Months Ended
	Dec. 31, 2020
Fair Value Measurements of Financial Instruments [Abstract]
Fair Value Measurements of Financial Instruments	1 1 . Fair Value Measurements of Financial Instruments  The following table summarizes our financial assets and liabilities measured at fair value on a recurring basis as of December 31, 20 20 :      Description Level 1 Level 2 Level 3 Gains (Losses)  Goodwill (non-recurring) $ — $ — $ 496,352 $ —  Intangibles, net (non-recurring) $ — $ — $ 1,368,329 $ —  The following table summarizes our financial assets and liabilities measured at fair value on a recurring basis as of December 31, 201 9 :      Description Level 1 Level 2 Level 3 Gains (Losses)  Goodwill (non-recurring) $ — $ — $ 496,352 $ —  Intangibles, net (non-recurring) $ — $ — $ 1,762,211 $ —  The Company recorded goodwill, intangible assets and an earn-out payable as a result its business combinations, and these assets were valued with the assistance of a valuation consultant and consisted of Level 3 valuation techniques.  The Company’s financial instruments consist of cash, accounts receivable, accounts payable, and accrued liabilities. The estimated fair value of cash, accounts receivable, accounts payable and accrued liabilities approximate their carrying amounts due to the short-term nature of these instruments. None of these instruments are held for trading purposes.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2020
Commitments and Contingencies [Abstract]
Commitments and Contingencies	12 . Commitments and Contingencies  Litigation  As of the date of this report, there are no pending legal proceedings to which we or our properties are subject, except for routine litigation incurred in the normal course of business.  Operating Lease  As described in Note 6, the Company has a lease through January 2021 for 10,395 square feet of office space located at 55 N. Arizona Ave., Suite 310, Chandler, Arizona. Monthly rental payments, excluding common area maintenance charges, are $20,140 . As of December 31, 20 20 , we have a n operating lease asset balance for this lease of $17,449 and an operating lease liability balance for this lease of $20,028 recorded in accordance with ASC 84 2 .  We have entered into a new lease starting in February of 2021 for 8,898 square feet of office space located at 3133 W. Frye Road, Suite 215, Chandler, Arizona. Monthly rental payments, excluding common area maintenance charges, will be $25,953 to $28,733 . The first twelve months of the lease includes a 50% abatement period. An operating lease asset and liability will be recorded when the lease commences in accordance with ASC 842.  The Company also has a lease through April 202 2 for 3,248 square feet of office space located in Halifax, Nova Scotia, at a monthly rental expense of $3,371 per month, excluding common area maintenance charges. As of December 31, 20 20 , we have a n operating lease asset balance for this lease of $17,449 and an operating lease liability balance for this lease of $20,028 recorded in accordance with ASC 84 2 .

Employee Benefit Plan

Employee Benefit Plan	12 Months Ended
	Dec. 31, 2020
Employee Benefit Plan [Abstract]
Employee Benefit Plan	1 3 . Employee Benefit Plan  The Company has an employee savings plan (the “Plan”) pursuant to Section 401(k) of the Internal Revenue Code (the “Code”), covering all of its employees. Participants in the Plan may contribute a percentage of compensation, but not in excess of the maximum allowed under the Code. The Company may make contributions at the discretion of its Board of Directors. During the years ended December 31, 20 20 and 201 9 , the Company made no contributions to the Plan.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2020
Related Party Transactions [Abstract]
Related Party Transactions	14. Related Party Transactions  Unsecured Promissory Note Investments in 20 19  During the year ended December 31, 2018 , we commenced an offer to certain investors, officers and directors of the Company Unsecured Promissory Notes (individually, a “ Note ” and collectively, the “ Notes ”). In 2019, we issued to one of our directors, unsecured Notes in the principal aggregate amount of $3,500,000 , which are due and payable two years after issuance . These notes bear interest on the unpaid balance at the rate of fifteen percent ( 15% ) per annum. The Company may prepay any of the Notes without notice, subject to a two percent ( 2% ) pre-payment penalty. We conducted the private placement of our securities in July 2019. The Note holder participated in the private placement by settling principal of $2,500,000 and accrued interest under the notes totaling $82,916 , for 2,582,916 units of our securities. The remaining 2019 Notes for $1,000,000 aggregated principal were settled with the December of 2020 private placement. As of December 31, 2020, we have $80,000 as a remaining balance of these Notes and accrued interest of $33,533 .  Unsecured Promissory Note Investments in 2 020  On February 26, 2020, we issued an unsecured Note in the principle aggregate amount of $200,000 , which becomes due two years after the date of issuance. This Note bears interest on the unpaid balance at the rate of fifteen percent ( 15% ) per annum. The Company may prepay this Note without notice, subject to a two percent ( 2% ) pre-payment penalty.  On November 18, 2020, we issued two additional unsecured Notes in the principle aggregate amount of $500,000 , which becomes due two years after the date of issuance. This Note bears interest on the unpaid balance at the rate of fifteen percent ( 15% ) per annum. The Company may prepay this Note without notice, subject to a two percent ( 2% ) pre-payment penalty.  On December 31, 2020 $1,200,000 of these Notes and the accrued interest of $192,208 was settled into equity and we recorded a loss on settlement of debt of $668,260 for the year ended December 31, 2020. In summary, as of December 31, 2020, we have a principal balance of $580,000 and accrued interest of $42,492 outstanding.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2020
Subsequent Events [Abstract]
Subsequent Events	15. Subsequent Events  Office Relocation  We have entered into a six-year office lease starting in February of 2021 for 8,898 square feet of office space located at 3133 W. Frye Road, Suite 215, Chandler, Arizona. Monthly rental payments, excluding common area maintenance charges, will be $25,953 to $28,733 . The first twelve months of the lease includes a 50% abatement period.  Intellectual Property  U.S. Patent number 10,949,868 B1 was granted on March 16, 2021. This patent covers the single use of electronic retailer coupons and referral program. The method and system prevents fraud, is specific to geolocation and provides an audit trail of the customer, cashier and marketing platform. A user can also earn a subsequent coupon by referring a friend.

The Company and Summary of Si_2

The Company and Summary of Significant Accounting Policies (Policy)	12 Months Ended
	Dec. 31, 2020
The Company and Summary of Significant Accounting Policies [Abstract]
The Company	The Company  Mobivity Holdings Corp. (the “Company” or “we”) is in the business of developing and operating proprietary platforms over which brands and enterprises can conduct national and localized, data-driven marketing campaigns.  Mobivity’s Recurrency platform enables multi-unit retailers to leverage the power of their own data to yield maximum customer spend, frequency and loyalty while achieving the highest Return on Marketing Spend (ROMS) possible. Mobivity’s customers use Recurrency to: · Transform messy point-of-sale (POS) data collected from thousands of points of sale into usable intelligence. · Measure, predict, and boost guest frequency and spend by channel. · Deploy and manage one-time use offer codes and attribute sales accurately across every channel, promotion and media program. · Deliver 1:1 promotions and offers with customized Mobile Messaging, Personalized Receipt Promotions and Integrated Loyalty programs. Mobivity’s Recurrency, delivered as a SaaS platform, is used by leading brands including Subway, Sonic Drive-In, Chick-fil-A , Checkers/Rally’s and Circle K’s across more than 40,000 retail locations globally. We’re living in a data-driven economy. In fact, by 2003 — when the concept of “big data” became common vernacular in marketing - as much data was being created every two day as had been created in all of time prior to 2003. Today, Big Data has grown at such a rate that 90% of the world’s data has been created in the past two years. Unfortunately, despite there being so much data accumulated, only one percent of data is being utilized today by most businesses.  The challenge for multi-unit retailers isn’t that they don’t have enough data; in fact, national retailers are collecting millions of detailed transactions daily from thousands of points of sale around the world. The challenge is being able to make sense of this transaction data, which is riddled with data entry errors, collected by multiple POS systems and complicated by a taxonomy compiled by thousands of different franchisee owners. To normalize such an overwhelming amount of data into usable intelligence and then leverage it to optimize media investment and promotion strategy requires numerous teams of data analysts and data scientists that many retailers and restaurant operators simply don’t have. Which is why so many technology and data companies, that can help solve these challenges, have been invested in and acquired by brands including, McDonald’s, Starbucks and Yum Brands.  Mobivity’s Recurrency platform fills this need with a self-service SaaS offering, enabling operators to intelligently optimize their promotions, media and marketing spend. Recurrency drives system-wide sales producing on average a 13% increase in guest spend and a 26% improvement in frequency, ultimately delivering an average Return on Marketing Spend of 10X. In other words, for every dollar invested in marketing, retailers using Recurrency to manage, optimize and deliver multi-channel consumer promotions generate an average of ten dollars in incremental revenue from their customers.  We generate revenue by charging the resellers, brands and enterprises a per-message transactional fee, or through fixed or variable software licensing fees.
Liquidity	Liquidity  We have $3,282,820 of cash as of December 31, 20 20 . We had a net loss of $ 2.9 million for the year then ended, and we used $ 1.3 million of cash in our operating activities during 20 20 . In 2019, we had a net loss of $8.8 million and used $5.7 million of cash in our operating expenses. Based on our projected results for the 12 month period from the date of this report and, if necessary, our ability to reduce certain variable operating expenses, we believe that our existing capital, and operations, will be sufficient to finance our operations through 20 21 . 
Principles of Consolidation and Basis of Presentation	Principles of Consolidation and Basis of Presentation  The accompanying financial statements are consolidated and include the financial statements of Mobivity Holdings Corp. , and our wholly-owned subsidiary. Intercompany transactions are eliminated.
Use of Estimates	Use of Estimates  Preparation of our consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP) requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying disclosures. These estimates are based on management's best knowledge of current events and actions we may undertake in the future. Significant estimates used are those related to: stock-based compensation; valuation of acquired assets, intangible assets and liabilities; useful lives for depreciation and amortization of long-lived assets; future cash flows associated with impairment testing for goodwill, indefinite-lived intangible assets and other long-lived assets; valuation of derivative liabilities; valuation allowance for deferred tax assets; and contingencies.  Actual results may ultimately differ from estimates, although management does not generally believe such differences would materially affect the consolidated financial statements in any individual year. However, in regard to ongoing impairment testing of goodwill and indefinite-lived intangible assets, significant deterioration in future cash flow projections or other assumptions used in estimating fair values versus those anticipated at the time of the initial valuations, could result in impairment charges that materially affect the consolidated financial statements in a given year.
Reclassifications	Reclassifications  Certain prior year amounts have been reclassified to conform to the current year’s presentation. The reclassifications had no effect on previously reported net loss.
Acquisitions	Acquisitions  We account for acquired businesses using the purchase method of accounting. Under the purchase method, our consolidated financial statements reflect the operations of an acquired business starting from the completion of the acquisition. In addition, the assets acquired and liabilities assumed are recorded at the date of acquisition at their respective estimated fair values, with any excess of the purchase price over the estimated fair values of the net assets acquired recorded as goodwill.
Cash and Cash Equivalents	Cash and Cash Equivalents  We minimize our credit risk associated with cash by periodically evaluating the credit quality of our primary financial institution. Our balances at times may exceed federally insured limits. We have not experienced any losses on our cash accounts.
Accounts Receivable, Allowance for Doubtful Accounts and Concentrations	Accounts Receivable, Allowance for Doubtful Accounts and Concentrations  Accounts receivable are carried at their estimated collectible amounts. We grant unsecured credit to substantially all of our customers. Ongoing credit evaluations are performed, and potential credit losses are charged to operations at the time the account receivable is estimated to be uncollectible. Since we cannot necessarily predict future changes in the financial stability of our customers, we cannot guarantee that our reserves will continue to be adequate.  As of December 31, 20 20 and 201 9 , we recorded an allowance for doubtful accounts of $33,848 and $88,071 , respectively.  From time to time, we may have a limited number of customers with individually large amounts due. Any unanticipated change in one of the customer’s credit worthiness could have a material effect on the results of operations in the period in which such changes or events occurred.  As of December 31, 20 20 , we had two customer whose balance represented 75% of total accounts receivable. As of December 31, 201 9 , we had two customer s whose balance represented 53% of total accounts receivable.
Goodwill and Intangible Assets	Goodwill and Intangible Assets  Goodwill is tested for impairment at a minimum on an annual basis. Goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. If the reporting unit does not pass the qualitative assessment, then the reporting unit's carrying value is compared to its fair value. The fair values of the reporting units are estimated using market and discounted cash flow approaches. Goodwill is considered impaired if the carrying value of the reporting unit exceeds its fair value. The discounted cash flow approach uses expected future operating results. Failure to achieve these expected results may cause a future impairment of goodwill at the reporting unit.  We conducted our annual impairment tests of goodwill as of December 31, 20 20 and 201 9 . As a result of these tests, we did no t record impairment charges .  Intangible assets consist of patents and trademarks, purchased customer contracts, purchased customer and merchant relationships, purchased trade names, purchased technology, and non-compete agreements. Intangible assets are amortized over the period of estimated benefit using the straight-line method and estimated useful lives ranging from one to twenty years. No significant residual value is estimated for intangible assets. We evaluate long-lived assets (including intangible assets) for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. An asset is considered impaired if its carrying amount exceeds the undiscounted future net cash flow the asset is expected to generate.  The Company’s evaluation of its long-lived assets completed res ulted in no impairment charges during the years ended December 31, 2020 and December 31, 2019.
Software Development Costs	Software Development Costs Software development costs include direct costs incurred for internally developed products and payments made to independent software developers and/or contract engineers. The Company accounts for software development costs in accordance with the FASB guidance for the costs of computer software to be sold, leased, or otherwise marketed (“ASC Subtopic 985-20”). Software development costs are capitalized once the technological feasibility of a product is established and such costs are determined to be recoverable. Technological feasibility of a product encompasses technical design documentation and integration documentation, or the completed and tested product design and working model. Technological feasibility is evaluated on a project-by-project basis. Amounts related to software development that are not capitalized are charged immediately to the appropriate expense account. Amounts that are considered ‘research and development’ that are not capitalized are immediately charged to engineering, research, and development expense. Capitalized costs for those products that are cancelled or abandoned are charged to impairment expense in the period of cancellation. Commencing upon product release, capitalized software development costs are amortized to “Amortization Expense - Development” based on the straight-line method over a twenty-four month period. The Company evaluates the future recoverability of capitalized software development costs on an annual basis. For products that have been released in prior years, the primary evaluation criterion is ongoing relations with the customer. The Company’s evaluation of its capitalized software development asset resulted in impairment charges of $8,886 for the year ended December 30, 2020 and $0 for the year ended December 31, 2019 .
Derivative Financial Instruments	Derivative Financial Instruments  We do not use derivative instruments to hedge exposures to cash flow, market or foreign currency risks.  We review the terms of the common stock, warrants and convertible debt we issue to determine whether there are embedded derivative instruments, including embedded conversion options, which are required to be bifurcated and accounted for separately as derivative financial instruments. In circumstances where the host instrument contains more than one embedded derivative instrument, including the conversion option, that is required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.
Revenue Recognition and Concentrations	Revenue Recognition and Concentrations  Our Recurrency platform is a hosted solution. We generate revenue from licensing our software to clients in our software as a service model, per-message and per-minute transactional fees, and customized professional services. We recognize license/subscription fees over the period of the contract, service fees as the services are performed, and per-message or per-minute transaction revenue when the transaction takes place. Under Topic 606, revenue is recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. We consider authoritative guidance on multiple deliverables in determining whether each deliverable represents a separate unit of accounting. Some customers are billed on a month to month basis with no contractual term and are collected by credit card. Revenue is recognized at the time that the services are rendered, and the selling price is fixed with a set range of plans. Cash received in advance of the performance of services is recorded as deferred revenue.  During the years ended December 31, 20 20 and 201 9 , two customers accounted for 77% and 70% of our revenues, respectively.
Stock-based Compensation	Stock-based Compensation  We primarily issue stock-based awards to employees in the form of stock options. We determine compensation expense associated with stock options based on the estimated grant date fair value method using the Black-Scholes valuation model. We recognize compensation expense using a straight-line amortization method over the respective vesting period.
Research and Development Expenditures	Research and Development Expenditures  Research and development expenditures are expensed as incurred, and consist primarily of compensation costs, outside services, and expensed materials.
Advertising Expense	Advertising Expense  Direct advertising costs are expensed as incurred and consist primarily of E-commerce advertisements , sales enablement, content creation, and other direct costs. Advertising expense was $399,266 and $40,993 for years ended December 31, 20 20 and 201 9 , respectively. We also include the cost of attending trade shows under marketing expense. We recorded $81,852 and $139,392 of expense related to those activities for the years ended December 31, 20 20 and 201 9 , respectively.
Income Taxes	Income Taxes  We account for income taxes using the assets and liability method, which recognizes deferred tax assets and liabilities determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to affect taxable income. Valuation allowances are established to reduce deferred tax assets when, based on available objective evidence, it is more likely than not that the benefit of such assets will not be realized. We recognize in the consolidated financial statements only those tax positions determined to be more likely than not of being sustained.
Computation of Net Loss Per Common Share	Computation of Net Loss per Common Share  Basic net loss per share is based upon the weighted average number of common shares outstanding. Diluted net loss per share is based on the assumption that all potential common stock equivalents (convertible notes payable, stock options, and warrants) are converted or exercised. The calculation of diluted net loss per share excludes potential common stock equivalents if the effect is anti-dilutive. Our weighted average common shares outstanding for basic and diluted are the same because the effect of the potential common stock equivalents is anti-dilutive.  We had the following dilutive common stock equivalents as of December 31, 20 20 and 201 9 which were excluded from the calculation because their effect was anti-dilutive.      December 31,  20 20 201 9  Outstanding employee options 6,007,552 5,781,884  Outstanding restricted stock units 1,436,728 1,152,248  Outstanding warrants 2,691,459 3,358,459  10,135,739 10,292,591 
Recent Accounting Pronouncements	Recent Accounting Pronouncements  Accounting standards promulgated by the FASB are subject to change. Changes in such standards may have an impact on the Company’s future financial statements. The following are a summary of recent accounting developments. In February 201 6, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-02, “Leases (Topic 842)”. Under this guidance, an entity is required to recognize right-of-use assets and lease liabilities on its balance sheet and disclose key information about leasing arrangements. This guidance offers specific accounting guidance for a lessee, a lessor and sale and leaseback transactions. Lessees and lessors are required to disclose qualitative and quantitative information about leasing arrangements to enable a user of the financial statements to assess the amount, timing and uncertainty of cash flows arising from leases. This guidance is effective for annual reporting periods beginning after December 15, 2018, including interim periods within that reporting period, and requires a modified retrospective adoption, with early adoption permitted. The Company adopted this standard as of January 1, 2019.  In November 201 6, the FASB issued ASU No. 2016-18, “Statement of Cash Flows (Topic 230).” ASU No. 2016-18 requires that restricted cash be included with cash and cash equivalents when reconciling the change in cash flow. The Company adopted this standard as of January 1, 2019.

The Company and Summary of Si_3

The Company and Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2020
The Company and Summary of Significant Accounting Policies [Abstract]
Dilutive common stock equivalents	We had the following dilutive common stock equivalents as of December 31, 20 20 and 201 9 which were excluded from the calculation because their effect was anti-dilutive.      December 31,  20 20 201 9  Outstanding employee options 6,007,552 5,781,884  Outstanding restricted stock units 1,436,728 1,152,248  Outstanding warrants 2,691,459 3,358,459  10,135,739 10,292,591 

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2020
Goodwill and Intangible Assets [Abstract]
Goodwill	The following table presents goodwill and impairment for the years ended December 31, 20 20 and 201 9 :      Goodwill  December 31, 2018 $ 537,550  Acquired (41,198)  Impairment —  December 31, 2019 496,352  Acquired —  Impairment —  December 31, 2020 $ 496,352 
Intangible Assets	The following table presents components of identifiable intangible assets for the years ended December 31, 20 20 and 201 9 :      December 31, 2020 December 31, 2019  Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Average Useful Life (Years) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Average Useful Life (Years)  Patents and trademarks $ 197,528 $ (126,499) $ 71,029 14 $ 183,583 $ (113,730) $ 69,853 14  Customer and merchant relationships 2,321,112 (1,678,727) 642,385 10 2,321,112 (1,581,876) 739,236 10  Trade name 197,950 (156,506) 41,444 10 197,924 (147,192) 50,732 10  Acquired technology 621,030 (492,539) 128,491 10 684,540 (539,748) 144,792 10  Non-compete agreement 79,299 (34,228) 45,071 2 79,299 (18,368) 60,931 2  $ 3,416,919 $ (2,488,499) $ 928,420 $ 3,466,458 $ (2,400,914) $ 1,065,544 
Future Amortization Intangible Assets	Expected future intangible asset amortization as of December 31, 20 20 is as follows:      Year ending December 31, Amount  2021 $ 147,992  2022 147,868  2023 145,359  2024 108,763  2025 101,015  Thereafter 277,423  Total $ 928,420 

Software Development Costs (Tab

Software Development Costs (Tables)	12 Months Ended
	Dec. 31, 2020
Software Development Costs [Abstract]
Software Development Costs	The following table presents details of our software development costs for the years ended December 31, 2020 and 2019:      December 31, 2020 December 31, 2019  Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Average Useful Life (Years) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Average Useful Life (Years)  $ 2,266,272 $ (1,826,364) $ 439,908 2 $ 2,245,811 $ (1,549,144) $ 696,667 2  $ 2,266,272 $ (1,826,364) $ 439,908 $ 2,245,811 $ (1,549,144) $ 696,667 
Future Amortization of Software	The estimated future amortization expense of software development costs as of December 31, 20 20 is as follows:      Year ending December 31, Amount  2021 345,643  2022 94,265  2023 —  2024 —  2025 —  Thereafter —  Total $ 439,908 

Operating Lease Assets (Tables)

Operating Lease Assets (Tables)	12 Months Ended
	Dec. 31, 2020
Operating Lease Assets [Abstract]
Additional Details Related to Leases on Balance Sheet	The following are additional details related to leases recorded on our b alance s heet as of December 31 , 2020 :     Leases Classification Balance at December 31, 2020  Assets  Current  Operating lease assets Operating lease assets $ 47,038  Noncurrent  Operating lease assets Noncurrent operating lease assets 10,444  Total lease assets $ 57,482   Liabilities  Current  Operating lease liabilities Operating lease liabilities $ 58,173  Noncurrent  Operating lease liabilities Noncurrent operating lease liabilities $ 13,296  Total lease liabilities $ 71,469 
Schedule of Minimum Lease Payments Including Weighted-Average Remaining Lease Term and Discount Rates	The maturity analysis below summarizes the remaining future undiscounted cash flows for our operating leases, a reconciliation to operating lease liabilities reported on the Condensed Consolidated Balance Sheet, our weighted-average remaining lease term and weighted average discount rate:      Year ending December 31, Amount  2021 $ 60,592  2022 13,484  2023 —  2024 —  2025 —  Thereafter —  Total future lease payments 74,076  Less: imputed interest (2,607)  Total $ 71,469      Weighted Average Remaining Lease Term (years)  Operating leases 0.57   Weighted Average Discount Rate  Operating leases 6.75% 

Notes Payable and Interest Ex_2

Notes Payable and Interest Expense (Tables)	12 Months Ended
	Dec. 31, 2020
Notes Payable and Interest Expense [Abstract]
Schedule of Notes Payable	The following table presents details of our notes payable as of December 31, 20 20 and 201 9 :      Facility Maturity Interest Rate Balance at December 31, 2020 Balance at December 31, 2019  BDC Term Loan October 15, 2021 23.5% $ 160,088 $ 224,307  ACOA Note February 1, 2024 — 111,430 117,131  Wintrust Bank November 1, 2021 Prime + 1.5% 366,667 766,667  TD Bank December 31, 2022 — 31,390 —  Chase Bank April 10, 2022 1% 891,102 —  Related Party Notes various 15% 580,000 1,140,700  Total Debt 2,140,677 2,248,805  Less current portion (641,676) (681,276)  Long-term debt, net of current portion $ 1,499,001 $ 1,567,529 
Schedule of Principal Payments on Notes Payable	Principal payments on notes payables are due as follows:      Year ending December 31, Amount  2021 $ 641,676  2022 1,462,121  2023 33,410  2024 3,470  2025 —  Thereafter —  Total future debt payments 2,140,677 
Summary of Interest Expense	The following table summarizes interest expense for the years ended December 31, 20 20 and 201 9 :      December 31,  2020 2019  Interest expense $ 286,896 $ 236,706  Total interest expense $ 286,896 $ 236,706 

Stock-based Plans and Stock-b_2

Stock-based Plans and Stock-based Compensation (Tables)	12 Months Ended
	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Option Activity	The following table summarizes stock option activity under our stock-based plans as of and for the years ended December 31, 20 20 and 201 9 :      Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Years) Aggregate Intrinsic Value  Outstanding at December 31, 2018 4,987,426 $ 1.16 7.12 $ 1,215,067  Granted 2,592,500 $ 1.01 — $ —  Exercised — —  Forfeit/canceled (923,389) $ 1.00 — $ —  Expired (874,653) $ 0.93 — $ —  Outstanding at December 31, 2019 5,781,884 $ 1.15 7.16 $ 527,868  Granted 1,545,000 $ 1.19 — $ —  Exercised (15,000) $ 0.48 — $ —  Forfeit/canceled (814,068) $ 0.94 — $ —  Expired (490,264) $ 1.07 — $ —  Outstanding at December 31, 2020 6,007,552 $ 1.20 6.77 $ 4,056,639   Expected to vest at December 31, 2020 6,007,552 $ 1.24 6.77 $ 4,056,639  Exercisable at December 31, 2020 3,477,356 $ 1.24 5.15 $ 2,252,766  Unrecognized expense at December 31, 2020 $ 1,734,104 
Stock-Based Compensation Expense	The impact on our results of operations of recording stock-based compensation expense for the years ended December 31, 20 20 and 201 9 was as follows:      Years Ended  December 31,  2020 2019  General and administrative $ 267,306 $ 670,188  Sales and marketing 75,235 74,229  Engineering, research, and development 171,394 155,475  $ 513,935 $ 899,892 
Valuation Assumptions	We calculated the fair value of each stock option award on the date of grant using the Black-Scholes option pricing model. The ranges of assumptions were used for the years ended December 31, 20 20 and 201 9 :      Years Ended  December 31,  2020 2019  Risk-free interest rate 0.42% to 0.58% 1.49% to 2.65%  Expected life (years) 6.00 6.06  Expected dividend yield — —  Expected volatility 77.36% to 78.21% 74.18% to 90.90% 
Restricted Stock Units RSU [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-Based Compensation Expense	The impact on our results of operations of recording stock-based compensation expense for years ended December 31, 20 20 and 201 9 was as follows:      Years Ended  December 31,  2020 2019  General and administrative $ 260,003 $ 263,378  $ 260,003 $ 263,378 
Restricted Stock Unit Activity	The following table summarizes restricted stock unit activity under our stock-based plans as of and for the years ended December 31, 20 20 and 201 9 :      Shares Weighted Average Grant Date Fair Value Weighted Average Remaining Contractual Term (Years) Aggregate Intrinsic Value  Outstanding at December 31, 2018 662,800 $ 0.72 0.70 $ 795,360  Awarded 489,448 $ 1.04 — $ 325,044  Released — $ — — $ —  Canceled/forfeited/expired — $ — — $ —  Outstanding at December 31, 2019 1,152,248 $ 0.86 — $ 1,120,404  Awarded 284,480 $ 0.91 — $ 60,003  Released — $ — — $ —  Canceled/forfeited/expired — $ — — $ —  Outstanding at December 31, 2020 1,436,728 $ 0.86 — $ 1,180,407   Vested at December 31, 2020 1,436,728 $ — — $ 2,428,070  Unvested at December 31, 2020 — $ — — $ —  Unrecognized expense at December 31, 2020 $ — 

Warrants to Purchase Common S_2

Warrants to Purchase Common Stock (Tables)	12 Months Ended
	Dec. 31, 2020
Warrants to Purchase Common Stock [Abstract]
Summary of Investor Warrant Activity	The following table summarizes investor warrant activity as of and for the years ended December 31, 20 20 and 201 9 :      Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Years)  Outstanding at December 31, 2018 2,112,060 $ 1.19 1.17  Granted 2,691,459 $ — —  Exercised — $ — —  Canceled/forfeited/expired (1,445,060) $ — —  Outstanding at December 31, 2019 3,358,459 $ 1.23 1.27  Granted 2,666,459 $ — —  Exercised (2,900,959) $ — —  Canceled/forfeited/expired (432,500) $ — —  Outstanding at December 31, 2020 2,691,459 $ 1.99 2.94 

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2020
Income Taxes [Abstract]
Provisions for Income taxes	For the years ended December 31, 20 20 and 201 9 the provisions for income taxes were as follows:     2020 2019  Federal – current $ — $ —  State – current — —  Foreign – current — —  Total $ — $ — 
Net Deferred Tax Assets and Liabilities	Significant components of our net deferred tax assets and liabilities as of December 31, 20 20 and 201 9 are as follows:     2020 2019  Deferred tax assets (liabilities):  Net operating loss carryforwards $ 14,881,000 $ 14,136,000  Stock based compensation 4,094,000 3,877,000  Accrued compensation 19,000 34,000  Depreciation and amortization 3,867,000 4,241,000  Other — 5,000  Total deferred tax assets 22,861,000 22,293,000  Valuation allowance for net deferred tax assets (22,861,000) (22,293,000)  Total $ — $ — 
Difference Between Provision for Income Taxes and Income Taxes Computed Using Federal Income Tax Rate	The difference between the provision for income taxes and income taxes computed using the U.S. federal income tax rate for the years ended December 31, 20 20 and 201 9 was as follows:     2020 2019  Computed expected tax expense $ (613,000) $ (1,853,000)  State taxes, net of federal benefit (141,000) (581,000)  Expiration of NOL carryforwards 44,000 44,000  Other 142,000 64,000  Change in valuation allowance 568,000 2,326,000  Total $ — $ — 

Fair Value Measurements of Fi_2

Fair Value Measurements of Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2020
Fair Value Measurements of Financial Instruments [Abstract]
Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis	The following table summarizes our financial assets and liabilities measured at fair value on a recurring basis as of December 31, 20 20 :      Description Level 1 Level 2 Level 3 Gains (Losses)  Goodwill (non-recurring) $ — $ — $ 496,352 $ —  Intangibles, net (non-recurring) $ — $ — $ 1,368,329 $ —  The following table summarizes our financial assets and liabilities measured at fair value on a recurring basis as of December 31, 201 9 :      Description Level 1 Level 2 Level 3 Gains (Losses)  Goodwill (non-recurring) $ — $ — $ 496,352 $ —  Intangibles, net (non-recurring) $ — $ — $ 1,762,211 $ — 

The Company and Summary of Si_4

The Company and Summary of Significant Accounting Policies (Narrative) (Details)	12 Months Ended
	Dec. 31, 2020USD ($)customeritem	Dec. 31, 2019USD ($)customer
Product Information [Line Items]
Average percent increase in guess spending using company platform	13.00%
Percent of improvement in frequency using company platform	26.00%
Cash including restricted cash	$ 3,282,820
Net loss	(2,918,397)	$ (8,821,974)
Net cash used in operating activities	(1,329,111)	(5,749,595)
Accounts receivable, allowance for doubtful accounts	33,848	88,071
Impairment charges on evaluation of goodwill	0	0
Intangible asset impairment	8,886
Impairment charges on long-lived assets	0	0
Advertising expense	399,266	40,993
Marketing expense	81,852	139,392
Computer Software Intangible Asset [Member]
Product Information [Line Items]
Intangible asset impairment	$ 8,886	$ 0
Estimated useful lives	2 years	2 years
Accounts Receivable [Member]
Product Information [Line Items]
Number of significant customers | customer	2	2
Customer concentration risk	75.00%	53.00%
Sales Revenue Net [Member]
Product Information [Line Items]
Number of significant customers | customer	2	2
Customer concentration risk	77.00%	70.00%
Minimum [Member]
Product Information [Line Items]
Number of retail locations where SaaS platform is used | item	40,000
Estimated useful lives	1 year
Maximum [Member]
Product Information [Line Items]
Estimated useful lives	20 years

The Company and Summary of Si_5

The Company and Summary of Significant Accounting Policies (Dilutive Common Stock Equivalents) (Details) - shares	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from calculation	10,135,739	10,292,591
Employee Stock Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from calculation	6,007,552	5,781,884
Restricted Stock Units RSU [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from calculation	1,436,728	1,152,248
Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from calculation	2,691,459	3,358,459

Acquisitions (Details)

Acquisitions (Details) - item	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Business Acquisition [Line Items]
Number of acquisitions	0	0

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets (Narrative) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Goodwill and Intangible Assets [Abstract]
Goodwill impairment	$ 0	$ 0
Amortization expense	150,701	178,653
Intangible asset impairment	$ 0	0
Acquired		$ (41,198)

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets (Goodwill) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Goodwill and Intangible Assets [Abstract]
Goodwill, Beginning Balance	$ 496,352	$ 537,550
Acquired		(41,198)
Impairment	0
Goodwill, Ending Balance	$ 496,352	$ 496,352

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets (Intangible Assets) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 3,416,919	$ 3,466,458
Accumulated Amortization	(2,488,499)	(2,400,914)
Total	928,420	1,065,544
Patents And Trademarks [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	197,528	183,583
Accumulated Amortization	(126,499)	(113,730)
Total	$ 71,029	$ 69,853
Weighted Average Useful Life (Years)	14 years	14 years
Customer and merchant Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 2,321,112	$ 2,321,112
Accumulated Amortization	(1,678,727)	(1,581,876)
Total	$ 642,385	$ 739,236
Weighted Average Useful Life (Years)	10 years	10 years
Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 197,950	$ 197,924
Accumulated Amortization	(156,506)	(147,192)
Total	$ 41,444	$ 50,732
Weighted Average Useful Life (Years)	10 years	10 years
Acquired technology [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 621,030	$ 684,540
Accumulated Amortization	(492,539)	(539,748)
Total	$ 128,491	$ 144,792
Weighted Average Useful Life (Years)	10 years	10 years
Noncompete Agreements [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 79,299	$ 79,299
Accumulated Amortization	(34,228)	(18,368)
Total	$ 45,071	$ 60,931
Weighted Average Useful Life (Years)	2 years	2 years

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets (Future Amortization Intangible Assets) (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Goodwill and Intangible Assets [Abstract]
2021	$ 147,992
2022	147,868
2023	145,359
2024	108,763
2025	101,015
Thereafter	277,423
Total	$ 928,420	$ 1,065,544

Software Development Costs (Nar

Software Development Costs (Narrative) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Finite-Lived Intangible Assets [Line Items]
Capitalized amount of software development	$ 266,365	$ 539,932
Amortization Of Intangible Assets	150,701	178,653
Computer Software Intangible Asset [Member]
Finite-Lived Intangible Assets [Line Items]
Amortization Of Intangible Assets	$ 518,087	$ 309,736
Estimated useful lives	2 years	2 years
Intangible asset impairment	$ 8,886	$ 0

Software Development Costs (Sof

Software Development Costs (Software Development Costs) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 2,266,272	$ 2,245,811
Accumulated Amortization	(1,826,364)	(1,549,144)
Net Carrying Amount	439,908	696,667
Computer Software Intangible Asset [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	2,266,272	2,245,811
Accumulated Amortization	(1,826,364)	(1,549,144)
Net Carrying Amount	$ 439,908	$ 696,667
Weighted Average Useful Life (Years)	2 years	2 years

Software Development Costs (Fut

Software Development Costs (Future Amortization of Software) (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Finite-Lived Intangible Assets [Line Items]
2021	$ 147,992
2022	147,868
2023	145,359
2024	108,763
2025	101,015
Thereafter	277,423
Total	928,420	$ 1,065,544
Computer Software Intangible Asset [Member]
Finite-Lived Intangible Assets [Line Items]
2021	345,643
2022	94,265
2023
2024
2025
Thereafter
Total	$ 439,908

Operating Lease Assets (Narrati

Operating Lease Assets (Narrative) (Details)	1 Months Ended	12 Months Ended			72 Months Ended
	Feb. 28, 2021USD ($)ft²	Jan. 31, 2022	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)	Jan. 31, 2027USD ($)
Lessee, Lease, Description [Line Items]
Amortization expense			$ (17,214)	$ 4,419
Rent expense			$ 317,774	$ 320,496
Lease Starting February 2021 [Member] | Forecast [Member] | Arizona [Member]
Lessee, Lease, Description [Line Items]
Lease abatement percentage		50.00%
Lease Starting February 2021 [Member] | Subsequent Event [Member] | Arizona [Member]
Lessee, Lease, Description [Line Items]
Area of office | ft²	8,898
Maximum [Member] | Lease Starting February 2021 [Member] | Forecast [Member] | Arizona [Member]
Lessee, Lease, Description [Line Items]
Monthly rental expense					$ 28,733
Maximum [Member] | Lease Starting February 2021 [Member] | Subsequent Event [Member] | Arizona [Member]
Lessee, Lease, Description [Line Items]
Rent expense	$ 28,733
Monthly rental expense	28,733
Minimum [Member] | Lease Starting February 2021 [Member] | Forecast [Member] | Arizona [Member]
Lessee, Lease, Description [Line Items]
Monthly rental expense					$ 25,953
Minimum [Member] | Lease Starting February 2021 [Member] | Subsequent Event [Member] | Arizona [Member]
Lessee, Lease, Description [Line Items]
Rent expense	25,953
Monthly rental expense	$ 25,953

Operating Lease Assets (Additio

Operating Lease Assets (Additional Details Related to Leases on Balance Sheet) (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Current
Operating lease assets	$ 47,038
Noncurrent
Operating lease assets	10,444	$ 260,645
Total lease assets	57,482
Current
Operating lease liabilities	58,173	258,343
Noncurrent
Operating lease liabilities	13,296	$ 45,460
Total lease liabilities	$ 71,469

Operating Lease Assets (Schedul

Operating Lease Assets (Schedule of Minimum Lease Payments Including Weighted-Average Remaining Lease Term and Discount Rates) (Details)	Dec. 31, 2020USD ($)
Operating Lease
2021	$ 60,592
2022	13,484
2023
2024
2025
Thereafter
Total future lease payments	74,076
Less: imputed interest	(2,607)
Total	$ 71,469
Weighted Average Remaining Lease Term (years) Operating leases	6 months 26 days
Weighted Average Discount Rate Operating leases	6.75%

Notes Payable and Interest Ex_3

Notes Payable and Interest Expense (Narrative) (Details)

Feb. 01, 2024USD ($)

Oct. 15, 2021CAD ($)

Sep. 15, 2021CAD ($)

Dec. 31, 2020USD ($)

Nov. 18, 2020USD ($)item

Feb. 26, 2020USD ($)

Jul. 02, 2019USD ($)

Nov. 14, 2018USD ($)

Nov. 14, 2019CAD ($)

Sep. 14, 2021CAD ($)

May 14, 2020CAD ($)

Mar. 14, 2021CAD ($)

Jul. 31, 2022CAD ($)

Dec. 31, 2020CAD ($)

Dec. 31, 2020USD ($)

Dec. 31, 2019USD ($)

Feb. 01, 2024USD ($)

Jul. 31, 2021CAD ($)

Oct. 31, 2019CAD ($)

Apr. 22, 2020CAD ($)

Apr. 10, 2019USD ($)

Feb. 28, 2018USD ($)

Debt Instrument [Line Items]

Debt Instrument Interest Rate Stated Percentage

15.00%

Principal payment

$ 10,485

Related Party Note

$ 1,080,000

Accrued interest

$ 47,316

$ 47,316

35,292

Loss on settlement of debt

$ (668,260)

(232,462)

ACOA Note [Member]

Debt Instrument [Line Items]

Maturity date

Feb. 1, 2024

Feb. 1, 2024

Principal payment

$ 88,000

$ 3,000

ACOA Note [Member] | Forecast [Member]

Debt Instrument [Line Items]

Principal payment

$ 2,215

$ 4,000

$ 4,500

$ 3,500

BDC Term Loan [Member]

Debt Instrument [Line Items]

Maturity date

Oct. 15, 2021

Oct. 15, 2021

Debt Instrument Interest Rate Stated Percentage

23.50%

23.50%

Principal payment

$ 8,500

$ 10,000

BDC Term Loan [Member] | Forecast [Member]

Debt Instrument [Line Items]

Principal payment

$ 80,000

$ 16,000

$ 12,000

Wintrust Loan [Member]

Debt Instrument [Line Items]

Proceeds from loan refinance

$ 1,000,000

Debt Instrument Face Amount

$ 1,000,000

Debt instrument description

The loan is a three-year loan and is interest-only payable for the first six months of the loan.

Principal payment

$ 33,333

$ 400,000

Wintrust Loan [Member] | Prime Rate [Member]

Debt Instrument [Line Items]

Basis spread on interest rate

1.50%

Chase Bank [Member]

Debt Instrument [Line Items]

Maturity date

Apr. 10, 2022

Apr. 10, 2022

Debt Instrument, Term

2 years

2 years

Debt Instrument Face Amount

$ 891,102

Debt Instrument Interest Rate Stated Percentage

1.00%

1.00%

TD Bank [Member]

Debt Instrument [Line Items]

Maturity date

Dec. 31, 2022

Dec. 31, 2022

Debt Instrument Face Amount

$ 40,000

Debt Instrument Interest Rate Stated Percentage

0.00%

0.00%

Percent of loan forgiven

25.00%

25.00%

Percent of loan repaid requirement for forgiveness

75.00%

75.00%

Unsecured Promissory Notes [Member]

Debt Instrument [Line Items]

Debt Instrument Face Amount

$ 3,500,000

$ 1,080,000

Debt Instrument Interest Rate Stated Percentage

15.00%

Debt instrument pre-payment penalty

2.00%

2.00%

Repayment of related party debt

$ 1,000,000

Related Party Note

80,000

Debt Conversion, Converted Instrument, Amount

$ 2,500,000

Debt instrument conversion, accrued interest

$ 82,916

Loss on settlement of debt

$ (232,462)

Unsecured Promissory Notes 3 [Member]

Debt Instrument [Line Items]

Debt Instrument, Term

2 years

Debt Instrument Face Amount

$ 200,000

Debt Instrument Interest Rate Stated Percentage

15.00%

Debt instrument pre-payment penalty

2.00%

Unsecured Promissory Notes 4 [Member]

Debt Instrument [Line Items]

Number of notes issued | item

2

Debt Instrument, Term

2 years

Debt Instrument Face Amount

$ 500,000

Debt Instrument Interest Rate Stated Percentage

15.00%

Debt instrument pre-payment penalty

2.00%

Unsecured Promissory Notes 5 [Member]

Debt Instrument [Line Items]

Principal balance outstanding

$ 580,000

$ 580,000

Accrued interest

42,492

42,492

Loss on settlement of debt

$ (668,260)

Unsecured Promissory Notes 5 [Member] | Principal [Member]

Debt Instrument [Line Items]

Debt Conversion, Converted Instrument, Amount

1,200,000

Unsecured Promissory Notes 5 [Member] | Accrued Interest [Member]

Debt Instrument [Line Items]

Debt Conversion, Converted Instrument, Amount

$ 192,208

Subsequent Event [Member] | BDC Term Loan [Member] | Forecast [Member]

Debt Instrument [Line Items]

Principal payment

$ 14,000

Notes Payable and Interest Ex_4

Notes Payable and Interest Expense (Schedule of Notes Payable) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Feb. 28, 2018
Debt Instrument [Line Items]
Interest Rate			15.00%
Total Debt	$ 2,140,677	$ 2,248,805
Less current portion	(641,676)	(681,276)
Long-term debt, net of current portion	$ 1,499,001	1,567,529
BDC Term Loan [Member]
Debt Instrument [Line Items]
Maturity date	Oct. 15, 2021
Interest Rate	23.50%
Total Debt	$ 160,088	224,307
ACOA Note [Member]
Debt Instrument [Line Items]
Maturity date	Feb. 1, 2024
Total Debt	$ 111,430	117,131
Wintrust Bank [Member]
Debt Instrument [Line Items]
Maturity date	Nov. 1, 2021
Total Debt	$ 366,667	766,667
Basis spread on interest rate	1.50%
TD Bank [Member]
Debt Instrument [Line Items]
Maturity date	Dec. 31, 2022
Interest Rate	0.00%
Total Debt	$ 31,390
Chase Bank [Member]
Debt Instrument [Line Items]
Maturity date	Apr. 10, 2022
Interest Rate	1.00%
Total Debt	$ 891,102
Related Party Note [Member]
Debt Instrument [Line Items]
Interest Rate	15.00%
Total Debt	$ 580,000	$ 1,140,700

Notes Payable and Interest Ex_5

Notes Payable and Interest Expense (Schedule of Principal Payments on Notes Payable) (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Notes Payable and Interest Expense [Abstract]
2021	$ 641,676
2022	1,462,121
2023	33,410
2024	3,470
2025
Thereafter
Total future debt payments	$ 2,140,677	$ 2,248,805

Notes Payable and Interest Ex_6

Notes Payable and Interest Expense (Summary of Interest Expense) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Notes Payable and Interest Expense [Abstract]
Interest expense	$ 286,896	$ 236,706
Total interest expense	$ 286,896	$ 236,706

Common Stock and Equity Payab_2

Common Stock and Equity Payable (Details)	Sep. 17, 2020$ / sharesshares	Mar. 02, 2020$ / sharesshares	Dec. 31, 2020USD ($)item$ / shares	Jul. 31, 2019$ / shares	Dec. 31, 2020USD ($)shares	Dec. 31, 2019USD ($)shares
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Shares issued | shares	15,000	234,500			1,113,767
Strike price per share | $ / shares	$ 0.48	$ 1
Issuance of common stock for debt conversion, Shares | shares						2,582,916
Proceeds from issuance of common stock, gross						$ 2,800,000
Ratio of converted warrant units | item			1
Offering Price | $ / shares				$ 1
Sale of common stock | shares					2,666,459	2,800,000
Proceeds from sale of common stock					$ 3,333,074
Loss on conversion					(668,260)	$ (232,462)
Stock-based compensation expense					260,003	263,378
Exercise Price | $ / shares				$ 1.25
Equity payable			$ 100,862		100,862	100,862
Warrant Issuance [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Stock-based compensation expense					0	0
Exercise Price | $ / shares			$ 1.25
New Warrant [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Exercise Price | $ / shares			$ 2
Principal [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Face amount					1,200,000	2,500,000
Accrued Interest [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Face amount					$ 192,208	$ 82,916

Stock-based Plans and Stock-b_3

Stock-based Plans and Stock-based Compensation (Narrative) (Details)	Dec. 17, 2020USD ($)employee$ / sharesshares	Dec. 07, 2020USD ($)employee$ / sharesshares	Nov. 05, 2020USD ($)employee$ / sharesshares	Aug. 07, 2020USD ($)$ / sharesshares	Apr. 06, 2020USD ($)employee$ / sharesshares	Mar. 24, 2020USD ($)employee$ / sharesshares	Dec. 31, 2019USD ($)$ / sharesshares	Nov. 19, 2019USD ($)employee$ / sharesshares	Oct. 21, 2019USD ($)employee$ / sharesshares	Aug. 21, 2019USD ($)employee$ / sharesshares	May 17, 2019USD ($)employee$ / sharesshares	Mar. 31, 2019USD ($)$ / sharesshares	Mar. 11, 2019USD ($)employee$ / sharesshares	Feb. 25, 2019USD ($)employee$ / sharesshares	Feb. 18, 2019USD ($)employee$ / sharesshares	Feb. 12, 2019USD ($)employee$ / sharesshares	Jan. 21, 2019USD ($)employee$ / sharesshares	Jan. 07, 2019USD ($)employee$ / sharesshares	Jan. 01, 2019USD ($)$ / sharesshares	Dec. 31, 2020USD ($)$ / sharesshares	Dec. 31, 2019USD ($)$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares authorized under stock plan																				3,477,356
Shares available for future grants																				33,032,730
Contractual terms (period)																				10 years
Options to purchase shares, in-the-money																				5,990,884
Weighted average grant date fair value | $ / shares																				$ 0.79	$ 0.71
Number of employees, options granted | employee	6	1	1		4	1		12	1	4	3		1	1	1	1	1	1
Options granted	210,000	600,000	20,000		700,000	15,000		237,500	150,000	140,000	1,775,000		50,000	50,000	15,000	150,000	15,000	10,000
Weighted average grant date fair value | $ / shares	$ 1.83	$ 1.55	$ 0.96		$ 0.70	$ 0.65		$ 0.88	$ 0.98	$ 0.95	$ 1.04		$ 1	$ 1	$ 1.05	$ 1	$ 1.17	$ 1.17
Monthly installments in which options vest, after initial vesting Anniversary	36 months	36 months	36 months			36 months		36 months	36 months	36 months	48 months			48 months	48 months	48 months	48 months	48 months
Volatility rate	77.41%	77.35%	77.36%		78.21%	77.56%		78.70%	74.18%	80.17%	80.17%		90.90%	90.88%	90.88%	90.79%	90.75%	90.82%
Call option value, price per share | $ / shares	$ 1.21	$ 1.03	$ 0.63		$ 0.47	$ 0.43		$ 0.60	$ 0.64	$ 0.65	$ 0.72		$ 0.75	$ 0.75	$ 0.84	$ 0.75	$ 0.88	$ 0.88
Call option value | $	$ 254,373	$ 615,495	$ 12,689		$ 326,752	$ 6,472		$ 142,409	$ 96,165	$ 91,537	$ 1,283,178		$ 37,688	$ 37,697	$ 12,537	$ 113,046	$ 13,239	$ 8,821
Proceeds from issuance of common stock, gross | $																					$ 2,800,000
Unearned stock based compensation expense | $																				$ 1,734,104
Thirty-Six Months [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options granted					500,000
Monthly installments in which options vest, after initial vesting Anniversary					36 months
Forty-Eight Months [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options granted					200,000								775,000
Monthly installments in which options vest, after initial vesting Anniversary					48 months								48 months
Immediately [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options granted													500,000
May 17, 2023 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options granted													500,000
Restricted Stock Units RSU [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Units issued	35,520		67,708	81,252		100,000	195,000					72,224							222,224	284,480	489,448
Value of units | $	$ 65,000		$ 65,000	$ 65,000		$ 65,000	$ 195,000					$ 65,001							$ 260,000
Value of units, per share | $ / shares	$ 1.83		$ 0.96	$ 0.80		$ 0.65	$ 1					$ 0.90							$ 1.17	$ 0.91	$ 1.04
Board compensation | $																				$ 260,003	$ 263,378

Stock-based Plans and Stock-b_4

Stock-based Plans and Stock-based Compensation (Stock Option Activity) (Details) - Employee Stock Option [Member] - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Outstanding at Beginning of Period	5,781,884	4,987,426
Granted	1,545,000	2,592,500
Exercised	(15,000)
Forfeit/canceled	(814,068)	(923,389)
Expired	(490,264)	(874,653)
Outstanding at End of Period	6,007,552	5,781,884	4,987,426
Expected to vest at End of Period	6,007,552
Exercisable at End of Period	3,477,356
Unrecognized expense at End of Period	$ 1,734,104
Weighted Average Exercise Price Per Share
Outstanding at Beginning of Period	$ 1.15	$ 1.16
Granted	1.19	1.01
Exercised	0.48
Forfeit/canceled	0.94	1
Expired	1.07	0.93
Outstanding at End of Period	1.20	$ 1.15	$ 1.16
Vested	1.24
Exercisable at end of period	$ 1.24
Weighted Average Remaining Contractual Life (Years)
Outstanding, Weighted Average Remaining Contractual Term (Years)	6 years 9 months 7 days	7 years 1 month 28 days	7 years 1 month 13 days
Expected, Weighted Average Remaining Contractual Term (Years)	6 years 9 months 7 days
Exercisable, Weighted Average Remaining Contractual Term (Years)	5 years 1 month 24 days
Aggregate Intrinsic Value
Aggregate Intrinsic Value, Outstanding	$ 4,056,639	$ 527,868	$ 1,215,067
Expected to vest at End of Period	4,056,639
Exercisable at End of Period	$ 2,252,766

Stock-based Plans and Stock-b_5

Stock-based Plans and Stock-based Compensation (Stock Based Compensation Expense - Stock Options) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 260,003	$ 263,378
Employee Stock Option [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	513,935	899,892
Employee Stock Option [Member] | General And Administrative [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	267,306	670,188
Employee Stock Option [Member] | Sales And Marketing [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	75,235	74,229
Employee Stock Option [Member] | Engineering, Research And Development [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 171,394	$ 155,475

Stock-based Plans and Stock-b_6

Stock-based Plans and Stock-based Compensation (Valuation Assumptions) (Details)	Dec. 17, 2020	Dec. 07, 2020	Nov. 05, 2020	Apr. 06, 2020	Mar. 24, 2020	Nov. 19, 2019	Oct. 21, 2019	Aug. 21, 2019	May 17, 2019	Mar. 11, 2019	Feb. 25, 2019	Feb. 18, 2019	Feb. 12, 2019	Jan. 21, 2019	Jan. 07, 2019	Dec. 31, 2020	Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected life (years)																6 years	6 years 22 days
Expected dividend yield																0.00%	0.00%
Expected volatility	77.41%	77.35%	77.36%	78.21%	77.56%	78.70%	74.18%	80.17%	80.17%	90.90%	90.88%	90.88%	90.79%	90.75%	90.82%
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate																0.42%	1.49%
Expected volatility																77.36%	74.18%
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate																0.58%	2.65%
Expected volatility																78.21%	90.90%

Stock-based Plans and Stock-b_7

Stock-based Plans and Stock-based Compensation (Restricted Stock Unit Activity) (Details) - USD ($)	Dec. 17, 2020	Nov. 05, 2020	Aug. 07, 2020	Mar. 24, 2020	Dec. 31, 2019	Mar. 31, 2019	Jan. 01, 2019	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Released, Shares
Forfeited, Shares
Unvested at end
Unrecognized expense at end
Exercised, Weighted Average Exercise Price
Forfeited, Weighted Average Exercise Price
Restricted Stock Units RSU [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding at Beginning of Period							662,800	1,152,248	662,800
Awarded, Shares	35,520	67,708	81,252	100,000	195,000	72,224	222,224	284,480	489,448
Outstanding at End of Period					1,152,248			1,436,728	1,152,248	662,800
Vested at end								1,436,728
Outstanding at beginning of period, Weighted Average Exercise Price							$ 0.72	$ 0.86	$ 0.72
Awarded, Weighted Average Grant Date Fair Value	$ 1.83	$ 0.96	$ 0.80	$ 0.65	$ 1	$ 0.90	$ 1.17	0.91	1.04
Outstanding at end of period, Weighted Average Exercise Price					$ 0.86			0.86	$ 0.86	$ 0.72
Expected to vest at end of period, Weighted Average Exercise Price
Outstanding, Weighted Average Remaining Contractual Term (Years)										8 months 12 days
Awarded, Aggregate Intrinsic Value								$ 60,003	$ 325,044
Outstanding, aggregate intrinsic value					$ 1,120,404			1,180,407	$ 1,120,404	$ 795,360
Vested, aggregate intrinsic value								$ 2,428,070

Stock-based Plans and Stock-b_8

Stock-based Plans and Stock-based Compensation (Stock Based Compensation Expense - Restricted Stock) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 260,003	$ 263,378
Restricted Stock Units RSU [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	260,003	263,378
Restricted Stock Units RSU [Member] | General And Administrative [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 260,003	$ 263,378

Warrants to Purchase Common S_3

Warrants to Purchase Common Stock (Narrative) (Details) - USD ($)	Mar. 02, 2020	Dec. 31, 2020	Dec. 31, 2019	Dec. 18, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense		$ 260,003	$ 263,378
Warrant term		10 years
Warrant Issuance [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense		$ 0	$ 0
Warrants to purchase of common stock		2,666,459
Warrants outstanding	234,500	2,691,459
Warrants outstanding, per share	$ 1	$ 1.25		$ 1.25
Adjustment to APIC	$ 234,500
Additional capital		$ 3,333,074
New Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants outstanding		2,666,459
Warrants outstanding, per share		$ 2
Warrant term		3 years

Warrants to Purchase Common S_4

Warrants to Purchase Common Stock (Summary of Investor Warrant Activity) (Details) - $ / shares	Dec. 17, 2020	Dec. 07, 2020	Nov. 05, 2020	Apr. 06, 2020	Mar. 24, 2020	Nov. 19, 2019	Oct. 21, 2019	Aug. 21, 2019	May 17, 2019	Mar. 11, 2019	Feb. 25, 2019	Feb. 18, 2019	Feb. 12, 2019	Jan. 21, 2019	Jan. 07, 2019	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted	210,000	600,000	20,000	700,000	15,000	237,500	150,000	140,000	1,775,000	50,000	50,000	15,000	150,000	15,000	10,000
Share-Based Compensation Arrangement By Share-Based Payment Award Equity Instruments Other Than Options Exercise In Period Weighted Average Exercise Price
Cancelled/forfeited/expired, Weighted Average Exercise Price
Investor Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding at Beginning of Period																3,358,459	2,112,060
Granted																2,666,459	2,691,459
Exercised																(2,900,959)
Canceled/forfeited/expired																(432,500)	(1,445,060)
Outstanding at End of Period																2,691,459	3,358,459	2,112,060
Outstanding at beginning of period, Weighted Average Exercise Price																$ 1.23	$ 1.19
Awarded, Weighted Average Grant Date Fair Value
Share-Based Compensation Arrangement By Share-Based Payment Award Equity Instruments Other Than Options Exercise In Period Weighted Average Exercise Price
Cancelled/forfeited/expired, Weighted Average Exercise Price
Outstanding at end of period, Weighted Average Exercise Price																$ 1.99	$ 1.23	$ 1.19
Outstanding, Weighted Average Remaining Contractual Term (Years)																2 years 11 months 9 days	1 year 3 months 7 days	1 year 2 months 1 day

Income Taxes (Narrative) (Detai

Income Taxes (Narrative) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Operating Loss Carryforwards [Line Items]
Change in valuation allowance	$ 568,000	$ 2,326,000
Change in ownership limit, operating loss	207,000
Pre change net operating loss carryforward	6,000,000
Liability for uncertain tax positions	0
Accrued interest and penalties	0
State And Local Jurisdiction [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	53,000,000
State And Local Jurisdiction [Member] | Earliest Tax Year [Member]
Operating Loss Carryforwards [Line Items]
Tax years subject to examination		2006
Domestic Country [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	$ 53,000,000
Domestic Country [Member] | Earliest Tax Year [Member]
Operating Loss Carryforwards [Line Items]
Tax years subject to examination		2006

Income Taxes (Provisions for In

Income Taxes (Provisions for Income Taxes) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Income Taxes [Abstract]
Federal - current	$ 0	$ 0
State - current	0	0
Foreign- current	0	0
Total	$ 0	$ 0

Income Taxes (Net Deferred Tax

Income Taxes (Net Deferred Tax Assets and Liabilities) (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Deferred tax assets (liabilities):
Net operating loss carryforwards	$ 14,881,000	$ 14,136,000
Stock based compensation	4,094,000	3,877,000
Accrued compensation	19,000	34,000
Depreciation and amortization	3,867,000	4,241,000
Other		5,000
Total deferred tax assets	22,861,000	22,293,000
Valuation allowance for net deferred tax assets	(22,861,000)	(22,293,000)
Total	$ 0	$ 0

Income Taxes (Difference Betwee

Income Taxes (Difference Between Provision for Income Taxes and Income Taxes Computed Using Federal Income Tax Rate) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Income Taxes [Abstract]
Computed expected tax expense	$ (613,000)	$ (1,853,000)
State taxes, net of federal benefit	(141,000)	(581,000)
Expiration of NOL carryforwards	44,000	44,000
Other	142,000	64,000
Change in valuation allowance	568,000	2,326,000
Total

Fair Value Measurements of Fi_3

Fair Value Measurements of Financial Instruments (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Fair Value Measurements Recurring [Member] | Fair Value Inputs Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Goodwill
Intangibles, net
Fair Value Measurements Recurring [Member] | Fair Value Inputs Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Goodwill
Intangibles, net
Fair Value Measurements Recurring [Member] | Fair Value Inputs Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Goodwill	496,352	496,352
Intangibles, net	1,368,329	1,762,211
Goodwill [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain (Loss) from fair value measurement
Intangible Assets [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain (Loss) from fair value measurement

Commitments and Contingencies (

Commitments and Contingencies (Details)	1 Months Ended	12 Months Ended		72 Months Ended
	Feb. 28, 2021USD ($)ft²	Jan. 31, 2022	Dec. 31, 2020USD ($)ft²	Jan. 31, 2027USD ($)	Dec. 31, 2019USD ($)
Commitments And Contingencies [Line Items]
Operating lease asset			$ 10,444		$ 260,645
Operating lease liability			$ 71,469
Lease Ending January 2021 [Member] | Arizona [Member]
Commitments And Contingencies [Line Items]
Area of property | ft²			10,395
Monthly rental expense			$ 20,140
Operating lease asset			17,449
Operating lease liability			20,028
Lease Starting February 2021 [Member] | Arizona [Member] | Subsequent Event [Member]
Commitments And Contingencies [Line Items]
Area of property | ft²	8,898
Lease Starting February 2021 [Member] | Arizona [Member] | Maximum [Member] | Subsequent Event [Member]
Commitments And Contingencies [Line Items]
Monthly rental expense	$ 28,733
Lease Starting February 2021 [Member] | Arizona [Member] | Minimum [Member] | Subsequent Event [Member]
Commitments And Contingencies [Line Items]
Monthly rental expense	$ 25,953
Lease Ending April 2022 [Member] | Halifax, Nova Scotia [Member]
Commitments And Contingencies [Line Items]
Monthly rental expense			$ 3,371
Lease area of office | ft²			3,248
Operating lease asset			$ 17,449
Operating lease liability			$ 20,028
Forecast [Member] | Lease Starting February 2021 [Member] | Arizona [Member]
Commitments And Contingencies [Line Items]
Lease abatement percentage		50.00%
Forecast [Member] | Lease Starting February 2021 [Member] | Arizona [Member] | Maximum [Member]
Commitments And Contingencies [Line Items]
Monthly rental expense				$ 28,733
Forecast [Member] | Lease Starting February 2021 [Member] | Arizona [Member] | Minimum [Member]
Commitments And Contingencies [Line Items]
Monthly rental expense				$ 25,953

Employee Benefit Plan (Details)

Employee Benefit Plan (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Employee Benefit Plan [Abstract]
Contributions to the Plan	$ 0	$ 0

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	Dec. 31, 2020	Nov. 18, 2020	Feb. 26, 2020	Jul. 02, 2019	Dec. 31, 2020	Jul. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Related Party Transaction [Line Items]
Accrued interest	$ 47,316				$ 47,316		$ 47,316	$ 35,292
Loss on conversion of debt							668,260	232,462
Unsecured Promissory Notes [Member]
Related Party Transaction [Line Items]
Aggregate principal amount settled					1,000,000
Director [Member] | Unsecured Promissory Notes [Member]
Related Party Transaction [Line Items]
Debt instrument principal amount								$ 3,500,000
Debt instrument term								2 years
Debt instrument interest rate								15.00%
Debt instrument pre-payment penalty								2.00%
Debt instrument conversion, principal						$ 2,500,000
Debt instrument conversion, accrued interest						$ 82,916
Debt converted into shares						2,582,916
Related party note	80,000				80,000		80,000
Accrued interest	33,533				33,533		33,533
Certain Investors, Officers and Directors [Member] | Unsecured Promissory Notes [Member]
Related Party Transaction [Line Items]
Debt instrument principal amount		$ 500,000	$ 200,000
Debt instrument term		2 years	2 years
Debt instrument interest rate		15.00%	15.00%
Debt instrument pre-payment penalty		2.00%	2.00%
Debt instrument conversion, principal	1,200,000
Debt instrument conversion, accrued interest	192,208
Related party note	580,000				580,000		580,000
Accrued interest	42,492				$ 42,492		$ 42,492
Loss on conversion of debt	$ 668,260
Unsecured Promissory Notes [Member]
Related Party Transaction [Line Items]
Debt instrument pre-payment penalty							2.00%
Debt instrument conversion, principal				$ 2,500,000
Debt instrument conversion, accrued interest				$ 82,916
Loss on conversion of debt								$ 232,462

Subsequent Events (Details)

Subsequent Events (Details) - Lease Starting February 2021 [Member]	1 Months Ended	12 Months Ended	72 Months Ended
	Feb. 28, 2021USD ($)ft²	Jan. 31, 2022	Jan. 31, 2027USD ($)
Subsequent Event [Member]
Subsequent Event [Line Items]
Operating lease term	6 years
Arizona [Member] | Forecast [Member]
Subsequent Event [Line Items]
Lease abatement percentage		50.00%
Arizona [Member] | Minimum [Member] | Forecast [Member]
Subsequent Event [Line Items]
Monthly rental expense			$ 25,953
Arizona [Member] | Maximum [Member] | Forecast [Member]
Subsequent Event [Line Items]
Monthly rental expense			$ 28,733
Arizona [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Area of property | ft²	8,898
Arizona [Member] | Subsequent Event [Member] | Minimum [Member]
Subsequent Event [Line Items]
Monthly rental expense	$ 25,953
Arizona [Member] | Subsequent Event [Member] | Maximum [Member]
Subsequent Event [Line Items]
Monthly rental expense	$ 28,733